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ABSTRACT 
 
THE EFFECT OF ASTYM® TREATMENT ON MUSCLE PERFORMANCE 
 
 
 
By 
Benjamin R. Kivlan 
December 2014 
 
Dissertation Supervised by RobRoy L. Martin PhD, PT 
Purpose:  Astym® treatment is a manual therapy intervention performed to stimulate 
tissue regeneration and treat pain, limited mobility, and muscle weakness for patients 
with musculoskeletal pathology.  The purpose of this study was to determine if Astym® 
treatment administered to the lower extremity of individuals with lower extremity 
musculoskeletal injuries would result in an immediate change of maximal force output 
during a unilateral isometric squat test.    
 
Subjects:  Forty-five subjects (14males; 31females) aged between 18-65 years 
participated in this study.  Criteria for inclusion in the study were: a lower extremity 
musculoskeletal injury with a resulting deficit of at least 10% in isometric squat strength 
of the involved limb; and a lower extremity functional score of 40-70 out of 80 points. 
 
  v 
Materials/Methods:  Subjects were randomized into 3 treatment groups (15 subjects per 
group):  1) Control – received no treatment 2) Placebo – received a sham Astym® 
treatment 3) Astym® Treatment – received Astym® treatment to the lower extremity.  
Subjects were blinded to whether they received the Astym® treatment or placebo 
treatment intervention.  After a 5-minute warm-up on a lower body ergometer the 
subjects were familiarized to the operations of a computerized leg press machine that 
measured the maximum force output (Newtons) during a unilateral isometric squat test.  
A baseline measure of maximal force output (pre-test) was determined by the average of 
3 trials with a 30 second rest period between the trials.  The subjects then received the 
designated treatment intervention.  Immediately following the treatment intervention the 
subjects were retested (post-test) using identical testing procedures by an investigator 
blinded to the treatment intervention received by the subject.  The percent change of 
maximal force output from pre-test to post-test measures was compared using a one-way 
analysis of variance with alpha set at 0.05. A Tukey’s post-hoc analysis determined 
statistical differences between the groups.  
 
Results:  A significant effect was observed on the percent change of maximal force 
output at the p<0.05 level for the Astym®, placebo, and control treatment interventions 
[F(2,42) = 7.91, p = 0.001].  Tukey’s post hoc analysis demonstrated that the percent 
change of maximal force output was significantly greater in the Astym® group 
(15+18%change) compared to the placebo (-6+11%change) and control(-1+17%change) 
groups.  No significant difference (p=0.68) was noted between the control and placebo 
groups.   
 vi 
Conclusions:  Astym® treatment to the involved lower extremity increases maximum 
force output during an isometric squat test immediately following treatment. A placebo 
treatment and a control treatment did not change maximal force output of the lower 
extremity.   
 
Clinical Relevance:  The results of this study suggest that Astym® treatment can be used 
as a treatment intervention for the immediate improvement of muscle performance for 
patients presenting with a muscle strength deficit caused by a musculoskeletal injury to 
the lower extremity.  This may expand the use of Astym® treatment for patients with 
muscular weakness in an effort to improve functional activities or athletic performance.  
The longevity of the effect of Astym® treatment on muscle performance, however, 
remains unknown.   
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Chapter 1 
 
 
Introduction 
 
 
1.1 Background 
 Physical therapists treat individuals with various types of injuries to the 
musculoskeletal system.  This includes soft-tissue injuries affecting muscles, tendons, 
fascia, joint capsules, and ligaments.  To treat soft-tissue injuries, physical therapists may 
employ various types of therapeutic interventions such as electrical stimulation, 
ultrasound, infrared laser, cryotherapy, strengthening exercises, and soft-tissue 
mobilization techniques. However, injuries to soft-tissue structures can be challenging to 
resolve and resilient to traditional therapeutic interventions.1  New soft-tissue 
mobilization techniques have evolved that utilize specialized instruments, tools, or 
devices to facilitate healing and address the impairments associated with soft-tissue 
injuries.2  Astym® treatment is an innovative instrument assisted soft-tissue mobilization 
technique that has been shown to stimulate soft-tissue regeneration and address common 
impairments such as pain, limitations in mobility, and muscle weakness that may 
accompany soft-tissue injury.1,3-11  
 Astym® treatment is a manual therapy technique applied with the use of 
specialized handheld instruments (Figure 1).1  The instruments are guided across the 
surface of an individual’s skin, parallel to the fiber orientation of the underlying soft-
tissue structures.1 These underlying ligamentous, deep fascial, muscular, and tendinous 
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tissues present with a different texture than the skin and superficial fascia.   This 
difference in texture can be felt through the Astym® instruments by the therapist.12  The 
therapist will judge the appropriate amount of pressure to apply with the instruments 
based on feeling the distinct texture of the ligamentous, deep fascial, muscular, and 
tendinous tissues  with the Astym instruments.12  Individuals that are lean will require 
less pressure through the instruments to contact the target tissues.12   Individuals that have 
greater adipose in the superficial fascia will require greater pressure applied through the 
instruments in order to feel the change of the tissue textures  necessary to mechanically 
stimulate underlying ligamentous, deep fascial, muscular, and tendinous tissues.12   
Mechanical stimulation of the soft-tissue structures initiates the body’s innate 
mechanisms of healing 13,14 and may reduce pain while improving mobility and muscle 
strength.1,3-11 Astym® treatment differs from other methods of soft-tissue mobilization 
techniques in that the treatment is administered to an entire limb segment with a specific, 
sequential protocol.  Thus a typical session of Astym® treatment incorporates treatment to 
soft-tissue structures proximal and distal to the focal area of injury or pathology. Each 
Astym® treatment session lasts approximately 15 minutes and is accompanied by 
stretching and strengthening exercises determined by the physical therapist.12  
 
The indications for Astym® treatment are pain, limited mobility, and impaired 
muscle performance as the result of common musculoskeletal pathologies. 5,11  Astym® 
treatment is believed to alter the recipient’s perception of pain through mechanical 
stimulation of soft tissues. In cases of chronic pain caused by soft-tissue dysfunction, 
Astym® treatment is thought to help the body absorb dysfunctional soft tissue and return 
it to a healthy, pain-free state.13-15  Several case studies have shown that Astym® 
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treatment can reduce pain caused by common musculoskeletal pathologies including 
epicondylosis 5, carpal tunnel syndrome,16 Achilles tendinopathy,8 hamstring 
tendinopathy 9 and patellar tendinopathy.17  Astym® treatment has also been successfully 
used to improve joint mobility as a result of excessive soft-tissue scarring and 
fibrosis.4,6,7,10  In two separate case studies, Henry et al.6,7 demonstrated clinically 
significant changes in knee joint range of motion in response to Astym® treatment when 
previous conservative and surgical interventions had failed. Astym® treatment was also 
used successfully to restore the range of motion to pre-injury levels in 2 separate cases of 
patients with ankle joint dysfunction caused by excessive fibrosis.10,11  Davies and 
Backopp 4 documented improvements in shoulder mobility in response to Astym® 
treatment for a series of patients with limited mobility of the shoulder after mastectomy 
surgery.   
Anecdotally, therapists have noted Astym® treatment invokes immediate 
improvements of muscle performance.  Muscle performance is described as the 
combination of the strength, power, and endurance of a muscle or group of muscles 
necessary to execute a specific task or functional activity.18  Because of the potential 
effects of Astym® treatment on muscular performance, athletes have begun receiving 
Astym® treatment before training sessions and competitions.19  However, only a few 
documented case studies have substantiated the influences of Astym® treatment on 
measures of muscle  performance.5,9  The impact of Astym® treatment on muscle 
performance is an area that needs to be studied in clinically controlled trials. 
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Figure 1.  Astym® Instruments  
 
Muscular strength is a component of muscle performance.  Muscular strength can 
be defined as the amount of maximal volitional force produced by the contraction of a 
single muscle or a group of muscles.20  Determining the effect of Astym® treatment on 
force output may impact how physical therapists implement a treatment program for a 
patient presenting with deficits in muscular strength due to common musculoskeletal 
pathologies.  Lower extremity muscular strength that is measured in the closed kinetic 
chain (ex. squat or leg press), is closely associated with the functional abilities of an 
individual.21 Unilateral squat strength has been associated with an individual’s ability to 
walk and negotiate stairs. 22 A deficit of lower extremity muscular strength has been 
shown to be a risk factor associated with falls in an elderly population. 23  In a younger, 
active population, squat strength is associated with athletic performance.  Comfort et al. 24 
demonstrated a significant negative correlation (r= -0.60) of squat strength to timed sprint 
speed in athletes and recreationally active, young men.  Parchmann & McBride 25 also 
demonstrated a relationship in maximal squat strength of collegiate athletes to sprint time 
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at 10 meters (r=-0.81) and 20 meters (r=-0.87), respectively.  The authors also found a 
strong relationship of maximal squat strength to vertical jump height (r=0.87) and agility 
test time (r=-0.76). 25 Based on the literature cited above, there is evidence to suggest that 
lower extremity muscular strength plays a moderate role in a wide variety of functional 
activities. 
To date, there is limited evidence to show that patients experience an increase in 
muscular performance as a result of Astym® treatment. 5,9 Anecdotally, physical 
therapists have noted post-treatment improvements of muscular strength quantified by 
handheld dynamometry of the musculotendinous structures treated with the Astym® 
instruments. Patients have also reported an immediate improvement of functional 
activities that require significant lower extremity muscular strength such as transitioning 
from sit to stand or climbing stairs.  However, none of these anecdotal findings have been 
studied in a randomized clinical trial.  This research project will determine if Astym® 
treatment improves immediate muscular performance for patients presenting with muscle 
weakness due to a musculoskeletal condition. The information gained from this research 
project will help determine if Astym® treatment has clinical application to improve 
muscle performance. Specifically, it will determine if Astym® treatment has a role in 
acutely improving muscular strength in an effort to enhance patient function.   
 
1.2 Operational Definitions  
 
 
Astym® treatment – An instrument assisted soft-tissue mobilization technique that is 
applied using specialized instruments and a specific sequential protocol to stimulate 
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tissue regeneration and for the treatment of pain, limited mobility, and muscle weakness 
related to common musculoskeletal conditions.   
 
Control group – The group of subjects that were randomized to receive no treatment 
intervention. 
 
Placebo group – The group of subjects that were randomized to receive a sham Astym® 
treatment that was performed using light pressure with the non-treatment edge of the 
Astym® instruments.   
 
Isometric Squat Test - A closed-kinetic chain physical performance test performed 
unilaterally on a leg press machine that records the force output produced from a static, 
pre-determined position of knee flexion and hip extension.  
 
Therapeutic soft-tissue mobilization - Manual therapy interventions directed to soft-tissue 
structures to increase joint range of motion, reduce pain, decrease swelling, increase 
flexibility, or improve muscle performance. 
 
Instrument assisted soft-tissue mobilization –Therapeutic soft-tissue mobilization 
techniques that utilize specialized tools or instruments for the purpose of treating 
common soft-tissue disorders. 
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Non-instrumented soft-tissue mobilization –Therapeutic mobilization techniques applied 
with the skilled hands of a trained healthcare professional to treat pain, swelling, limited 
flexibility, or impaired muscle performance with the goal to improve functional abilities 
of a patient.   
 
Muscle performance - The combination of muscle strength, power, and endurance 
necessary to execute a specific task or functional activity. 
 
Muscular strength- A component of muscle performance that describes the maximal force 
generated by the volitional contraction of a muscle or group of muscles. 
 
Pain - An unpleasant sensory or emotional experience associated with actual or potential 
tissue damage. 
 
Neuromuscular Facilitation - An increase of muscle activation through stimulation of the 
sensorimotor system.   
 
1.3  Limitations and Assumptions 
1.  Subjects consistently gave maximal effort during testing. 
2.  The delivery of Astym® treatment was consistent among subjects. 
3.  The time from the end of treatment intervention to the beginning of testing was the 
same for each subject. 
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4.  The sample of subjects recruited for this study was representative of a population 
of patients attending outpatient physical therapy for a lower extremity 
musculoskeletal injury.   
5.  Any observed differences in muscle strength were a result of whether the patient 
had received Astym® treatment, a sham Astym® treatment, or no treatment at all.   
6.  The results only represented acute changes in muscular strength. 
7.  The sustainability of any observed effects on muscular strength is unknown. 
8.  The functional impact of any observed effects of Astym® treatment on muscular 
strength remains unknown.   
 
1.4 Delimitations 
1.  Recruitment of 45 subjects from an outpatient sports medicine and orthopedic 
physical therapy clinic. 
2.  Randomization of subjects into a treatment group. 
3.  Primary investigator was blinded to the results of the isometric squat tests until all 
of the subjects had completed testing. 
4.  Secondary investigator and the subjects were blinded to the treatment intervention 
received.   
5.  Familiarization of the subjects to the operations of the computerized leg press 
machine to account for a learning effect. 
6.  Established a work:rest ratio to account for muscular fatigue during testing. 
7.  Astym® treatment was provided by the same provider, with 3 years of clinical 
experience administering the technique. 
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1.5 Problem Statement 
 The purpose of this study was to determine if Astym® treatment administered to 
the lower extremity resulted in an acute change of muscular performance as measured by 
maximal force output during an isometric squat test among subjects presenting with 
weakness associated with a musculoskeletal injury to the lower extremity. 
 
1.6 Independent Variable 
The Independent Variable in the present study was the treatment intervention 
administered to the subjects.  The treatment intervention had three forms: 
1. Control – received no treatment (12 minutes of rest) 
2. Placebo – received 12 minutes of a sham Astym® treatment to the lower extremity 
3. Astym® Treatment – received 12 minutes of Astym® treatment to the lower 
extremity 
 
1.7 Dependent Variable 
The present study investigated one dependent variable: 
1. Percent change (%change) of pre-treatment to post-treatment maximal force 
 output during an isometric squat test 
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1.8  Hypotheses 
 1.  Astym® treatment will have a significant effect on maximal force output during a 
unilateral isometric squat test.   
1a.  The group of subjects that receive Astym® treatment will produce a 
significantly greater percent change in pre-treatment to post-treatment 
maximal force output than the subjects that received no treatment (control) 
and the subjects that received a sham Astym® treatment (placebo). 
1b.  The percent change in pre-treatment to post-treatment maximal force 
output produced during an isometric squat test for the control and placebo 
groups will not be statistically different. 
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CHAPTER 2 
 
 
 
Review of Literature 
 
 
2.1 Introduction 
 
Astym® treatment is a manual therapy technique applied with specialized 
instruments by a physical therapist with advanced certification and training in the 
technique.   There are specific Astym® treatment protocols used in the treatment of 
pathologies of the upper extremity, shoulder complex, cervical-thoracic spine, lumbar 
spine, hip complex, and lower extremity.  Each of the Astym® treatment protocols 
addresses the entire kinetic chain that includes treatment to the body regions that are 
distal and proximal to the specific area of pathology.  For example, Astym® treatment for 
patellar tendinopathy includes treatment of the foot, ankle, and leg, as well as the 
structures of the hip complex and thigh.   Astym® treatment is used to stimulate tissue 
regeneration.  Astym® treatment may also be indicated to treat pain, limited mobility, and 
muscle weakness related to common musculoskeletal conditions.  Astym® treatment 
provides a mechanical stimulus to soft-tissue structures through the therapist’s 
application of the Astym® instruments.  There are three Astym® instruments of varying 
sizes that are used during each treatment session.  The larger instruments are used to 
perform longitudinal strokes over the entire length of musculotendinous structures from 
the origin to insertion.  This is followed by specific strokes using the smaller instruments 
over bony prominences where tendons and ligaments commonly attach.  A total of 2 sets 
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of strokes in a superior to inferior direction, followed by 2 sets of strokes in an inferior to 
superior direction are performed until the entire body region has been treated. The strokes 
are applied at a rate of 6-8 inches per second.  The amount of pressure applied through 
the instruments is enough to feel the unique texture of the ligaments, tendons, deep 
fascia, and muscular tissues that are deep to the skin and superficial fascia.  Because each 
individual possesses a different amount of adipose tissue within the superficial fascia, the 
amount of pressure applied through the instruments varies according to each individual’s 
body composition.  However, contact of the instruments with the muscle, tendon, deep 
fascia, and ligamentous tissues as determined by the unique texture that these structures 
provide remains consistent regardless of body composition.  Therefore, each Astym® 
treatment provides a consistent stimulation of the muscle, tendon, deep fascia, and 
ligamentous structures despite variability in body composition between individuals.  
Once the entire kinetic chain has been treated with all of the appropriate Astym® 
instruments in accordance to the regional Astym® protocol, the Astym® treatment is 
complete and the patient will perform additional therapeutic exercises and activities as 
determined by the physical therapist.   
 Despite limited evidence, Astym® treatment has shown promise as a therapeutic 
intervention to improve muscle performance.5,9 However, the acute effects of Astym® 
treatment on muscle performance have yet to be explored in a clinically controlled trial.  
The purpose of this literature review is to define the current understanding of the 
relationship of Astym® treatment to muscle performance.  Emphasis will be placed on 
reviewing peer-reviewed literature that explains the known and theorized physiological 
mechanisms of Astym® treatment as it pertains to muscle performance.  The review will 
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further encompass analysis of forms of instrumented and non-instrumented soft-tissue 
mobilization techniques employed by physical therapists and the impact of those 
interventions on muscle performance.  The review will conclude by comparing the 
theorized physiological mechanisms and outcomes related to muscle performance to 
other forms of instrument assisted and non-instrument assisted soft-tissue mobilization 
techniques.   
 
2.2  Influence of Soft-Tissue Mobilization on Muscle Performance 
 
 
Soft-tissue mobilization techniques facilitate several physiological changes that 
have the potential to affect muscle performance.  Specifically, soft-tissue treatments are 
believed to enhance muscle performance through neuromuscular facilitation (2.2.1), 
modulation of pain (2.2.2), mechanosensitivity of the muscle tissue (2.2.3), and increased 
blood flow (2.2.4).  The physiological mechanisms through which soft-tissue 
mobilization techniques, such as Astym® treatment, may act to enhance muscle 
performance are explored below. 
 
2.2.1  Neuromuscular Facilitation  
 
 Riemann and Lephart 26,27, and Voss et al.  26,27  have theorized that soft tissue-
mobilization techniques  may influence muscle performance through activation of the 
sensorimotor system.26,27 The sensorimotor system is responsible for resultant changes in 
motor or muscle activation that is directly or indirectly attributed to sensory 
stimulation.26,27 An increase of muscle activation through stimulation of the sensorimotor 
system is referred to as neuromuscular facilitation.27,28  The sensorimotor system receives 
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input from various types of somatosensory receptors found within the skin, fascia, 
ligaments, joint capsules, tendons, and muscle tissues. 27,28   The somatosensory receptors 
respond to stimuli such as pain, temperature, touch, vibration, and pressure.27,28  When 
stimulated the somatosensory receptors send input to the motor processing centers of the 
central nervous system.27,28 The pathway from the somatosensory receptors to the central 
motor processing centers is referred to as the afferent pathway.  The spinal cord, 
brainstem, cerebellum, and cerebral cortex collectively integrate afferent signals from the 
somatosensory receptors and respond by sending signals via motor neurons to the 
appropriate muscle tissue.27  The pathway from the central motor processing centers to 
the muscle tissue is known as the efferent pathway.  An important role of the 
somatosensory receptors is to provide feedback to the central nervous system about joint 
position, body movement, and length-tension relationships of muscle.  Improved 
awareness of joint position, body movement, and maintaining optimal length-tension 
relationship of muscles can positively influence muscle activation.29  Therefore, the 
stimulation of the somatosensory system is capable of influencing muscle performance.  
This section will describe the different types of somatosensory receptors and how 
stimulation of these receptors through specific therapeutic interventions facilitates 
muscular activation and influences muscle performance.   
2.2.1.1 Somatosensory Receptors 
 The soft tissues of the human body are richly innervated with several types of 
somatosensory receptors.  Muscle spindles and golgi tendon organs are two specialized 
receptors found within musculotendinous tissue.27  Muscle spindles are aligned in parallel 
to the extrafusal muscle fiber and are interspersed within a muscle belly.  Muscle spindles 
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are sensitive to passive changes in muscle length.  Rapid stretching of a muscle activates 
the muscle spindle, which in turn facilitates a contraction of the same muscle. 27  Golgi 
tendon organs are another type of somatosensory receptor commonly found at the 
musculotendinous junction of skeletal muscles.  Golgi tendon organs are aligned in series 
to the extrafusal muscle fibers and are sensitive to muscle tension developed during a 
muscle contraction.27  Stimulation of the Golgi tendon organs induce a spinal reflex that 
inhibits the stimulated muscle.27 Although the mechanisms that activate the muscle 
spindle and golgi tendon organs are different, both receptors monitor and help maintain 
adequate length-tension characteristics of the muscle that may influence muscular 
strength.27 
 In addition to the muscle spindles and golgi tendon organs, specialized 
somatosensory receptors can be found in cutaneous, fascial, ligamentous, and capsular 
tissues. Table 1 summarizes the various types of somatosensory receptors based on 
location and sensitivity to sensory stimuli. Pacinian corpuscles are common receptors 
found in the hypodermis of the skin as well as in fascial, ligamentous, muscular, and 
tendinous tissue. 27,30,31 Pacinian corpuscles are poor at responding to sustained pressure 
but are very good at detecting rapid changes of mechanical stimuli, particularly 
vibration.27,30,31 Ruffini endings are abundant throughout the dermis of the skin, 
subcutaneous tissue, capsular tissue, and ligaments of peripheral joints.  Ruffini endings 
are slow adapting receptors, making them able to detect stimuli of sustained pressure. 
The Ruffini endings are particularly sensitive to tangential forces that create shearing-like 
stress of tissue.27,30,31  Meissner Corpuscles are receptors found in the dermis layer of skin 
and are responsive to fine touch and tactile discrimination. 28,32 The most abundant 
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receptors found in the skin, muscular, fascial, and ligamentous structures are interstitial 
receptors.  A majority of interstitial receptors serve as mechanoreceptors that respond to 
mechanical tension and pressure.33 Interstitial receptors are often stimulated as a result of 
stretching of skin, muscle, and fascial tissue. 34  
 
Table 1.  Peripheral Cutaneous Somatosensory Receptors  
Receptor Location  Stimuli 
Pacinian  
Corpuscles 
 Muscle 
 Myotendinous junctions 
 Joint Capsule  
 Spinal Ligaments 
 Touch 
 Rapid change of pressure 
 Vibration 
Ruffini 
 Endings 
 Dermis of the skin 
 Subcutaneous tissue 
capsular 
 Ligaments  
 Sustained pressure 
 Shearing stress 
Meissner Corpuscles  Dermis layer of skin 
 
 Fine touch 
 Tactile discrimination 
Interstitial  Skin 
 Muscle 
 Fascia 
 Ligaments  
 Pain 
 Mechanical tension 
 Pressure 
 
 
2.2.1.2 Influence of Somatosensory Receptors on Muscle Performance 
The influence of somatosensory receptors on muscle performance is complex. 27  
The integration of sensory input to muscular output may best be explained by the final 
common input hypothesis.35  Based on the final common input hypothesis, sensory 
receptors from cutaneous, muscular, and articular sources, in addition to the motor 
centers of the central nervous system converge upon the gamma motor neurons. 35  The 
gamma motor neurons innervate muscle spindles, maintaining the sensitivity of the 
spindle to changes in length as the muscle shortens during contraction.27  Once activated, 
the muscle spindle acts upon muscle fibers via the alpha motor neuron.  According to the 
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final common input hypothesis, motor function can either be facilitated or inhibited by the 
input received from the somatosensory system.35 Whether the muscle is facilitated or 
inhibited may depend on the type of stimulation and ultimately the type of somatosensory 
receptor that is transmitting the input to the central nervous system.30   
 
Stimulation of somatosensory receptors can also influence muscle performance 
through stimulation of the autonomic nervous system. The autonomic nervous system 
controls hormonal responses, perfusion, and blood glucose levels that may influence 
force generation of voluntary muscle contraction.36 Stimulation of somatosensory 
receptors has been suggested to trigger sympathetic nervous system responses,37 while 
other sources report an increase of parasympathetic responses.33 The type of stimulation 
received by the somatosensory receptors may ultimately determine whether the 
sympathetic or parasympathetic nervous systems are stimulated. Static pressure has been 
shown to lower arterial blood pressure suggestive of parasympathetic nervous system 
stimulation.33 Slow rhythmic stroking of soft-tissue activates the parasympathetic nervous 
system, reducing muscle tone,38 skin temperature, and activation of the muscle spindle.30 
Conversely, tactile pressures applied with strong and rapid manipulation of soft-tissue 
activates a sympathetic nervous system response capable of inducing muscle 
contraction.30,39  The stimulus imparted by an Astym® treatment resembles the stimuli 
described for triggering sympathetic nervous system activation, but the effect of Astym® 
treatment on activation of the sympathetic nervous system has not been investigated.   
2.2.1.3  Therapeutic Applications of Neuromuscular Facilitation 
The facilitation of muscle performance through somatosensory stimulation has 
been the proposed physiologic mechanism behind many therapeutic interventions dating 
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back to the middle of the twentieth century.40,41 Dr. Margaret Rood developed methods to 
either facilitate or inhibit muscle activation with the purpose of normalizing motor 
function.40,41 The therapeutic interventions introduced by Dr. Rood became known as 
neurodevelopmental therapy.40,41 Neurodevelopmental therapy is based on the principle 
that therapeutic interventions provide a sensory stimulus that targets a specific sensory 
receptor to elicit a desired response.40,41  Rood proposed that therapeutic interventions 
that include rapid tissue stroking, fast brushing of the skin, and vibration facilitate muscle 
contraction.40,41  Although these therapeutic interventions have been commonly employed 
in clinical settings, there is limited evidence to support the idea that the techniques are 
capable of facilitating neuromuscular function and enhancing muscle performance.   
2.2.1.3.1  Tactile Stimulation 
 According to the original theories described by Rood 41, fast brushing of the skin 
causes a stimulation of the same somatosensory receptors that are sensitive to pain.  Rood 
believed the sensory stimulation from fast brushing would influence the muscle spindle to 
have a facilitatory effect on muscle activation.41,42  The facilitation of the muscle was 
believed to last up to 40 minutes after cessation of fast brushing.41,42  However, a study 
performed by Mason42 revealed no clear conclusion of the effect of tactile stimulation 
through fast brushing on muscle activation measured by electromyographic activity and 
muscular strength as measured by peak force production of the stimulated muscle.  
Mason42 tested the effect of 5 seconds and 30 seconds of brushing of the skin overlying 
the gastrocnemius muscle at speeds of 5, 180, and 360 revolutions per second in healthy 
subjects. The peak force and electromyographic activity of the gastrocnemius muscle in 
response to an Achilles reflex was recorded sequentially at 30 seconds following the 
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cessation of brushing and every 5 minutes thereafter for 30 minutes. The results of the 
study indicated that electromyographic activity of the gastrocnemius muscle was not 
significantly different from a control condition that did not receive the fast brushing 
stimulus.  The peak force production, however, was significantly different according to 
the analysis of variance, but was unable to show a significant effect for the different 
speeds, duration, and elapsed time from the fast brushing stimulus. In a similar study, 
Wood et al.43 demonstrated an inhibitory effect of the gastrocnemius-soleus muscle reflex 
in response to fast brushing among a group of healthy subjects.  Conversely, Matyas et 
al.44 demonstrated a significant effect of fast brushing on maximal volitional contraction 
of the hamstrings and quadriceps muscles among subjects with hemiplegia. These 
findings were consistent with those described by Garland and Hayes 45 who reported 
improved voluntary contraction of the tibialis anterior muscle in response to fast brushing 
among a group of individuals suffering from foot drop.  Based on the findings of these 
research studies it appears that the response to fast brushing in healthy subjects is 
equivocal or inhibitory to muscle activation. On the contrary, subjects with neurologic 
impairment experience a facilitatory muscle response.42-45 The authors of these studies 
concur that the influence of sensory stimulation on muscle activation and strength is 
complex and may depend on several intrinsic factors of the individual that may explain 
the variable response to the stimulation.40,42-45  
2.2.1.3.2 Vibration 
 Vibration is another sensory stimulus that has been proposed to have a facilitatory 
effect on muscle performance.  Therapeutic applications of vibration can be applied 
locally to a single muscle-tendon complex, to an entire limb segment, or through the 
entire body.46  The mechanical stimulation from a therapeutic application of vibration is 
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believed to stimulate the muscle spindle complex found within the muscle tissue. The 
stimulation of the muscle spindle increases excitability of motorneurons transmitting 
efferent signals to the muscles that received the mechanical stimulus from vibration.46 
The increase of motorneuron excitability has been substantiated with studies that 
demonstrate acute increases of electromyographic activity of muscles in response to 
vibration stimuli compared to control groups.47-53  The effects of vibration on cutaneous 
mechanoreceptors may last for several minutes post vibration stimulation.54 Reflex 
responses affecting motorneurons are also heightened following vibration stimulation 
when compared to non-vibration conditions. 51,55,56 
The acute effects of vibration on muscle performance, specifically muscle 
strength and power, have been well documented.  Bosco et al.57 studied the acute effects 
of vibration on single limb squat strength in elite volleyball players.  The subjects 
experienced a 6-8% increase in squat strength when tested immediately following whole-
body vibration.  Similar findings were reported for the elbow flexor muscles as 
electromyographic activity and muscle force production tested 5 minutes after vibration 
treatment to the entire upper extremity showed a significant improvement compared to a 
control group that did not receive upper extremity vibration.58  Issurin et al.59 
corroborated these findings with approximately 10% increases in muscular strength of the 
elbow flexor muscles with vibration stimulus to the entire upper extremity.  Mileva et 
al.60 demonstrated significantly greater muscular strength of the knee extensor muscles 
during trials superimposed with a form of vibratory stimulus to the quadriceps muscles 
when compared to performance without a vibratory stimulus.  Conversely, de Ruiter et 
al.61  demonstrated no significant effect of whole-body vibration on maximal voluntary 
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isometric knee extensor force.  In fact, they found an approximate 5% decrease in 
isometric knee extensor force.61   Cormie et al.62 also demonstrated a decline in muscular 
strength as determined by peak force during an isometric squat test.   However, in the 
studies by Cormie et al.62 and de Ruiter et al.61, the whole body vibration was applied 
while subjects assumed a squat position. This placed the knee angle of the subjects 
between 100-110° of flexion.  The position would require activation of the knee extensor 
muscles that could have fatigued the muscles prior to the post-treatment force testing. 
Research has demonstrated that vibration applied during muscle contraction or active 
exercise results in accelerated muscle fatigue.51 Therefore, differences in the application 
of the vibration may explain the contradictory results found for vibration and muscular 
strength. A recent meta-analysis of studies investigating the short-term effects of 
vibration on muscle performance concluded that vibration has an overall positive 
influence on muscular strength, specifically for the muscles involved in extension of the 
knee.63  Astym® treatment is hypothesized to stimulate the same somatosensory pathways 
as vibration and thus may share similar treatment effects on muscle performance. 
2.2.2 Pain Modulation 
Pain is defined as an unpleasant sensory or emotional experience associated with 
actual or potential tissue damage.64 Pain serves as a natural warning system to protect the 
body from impending damage through input from specialized receptors called 
nocioceptors.65 Nocioceptors elicit pain in response to mechanical, thermal, and chemical 
stimuli.65   Stimulation of nocioceptors has been shown to suppress muscle activation and 
decrease muscular strength.66-68 Conversely, when stimuli from nocioceptors are abated, 
muscular strength and activation is restored to pre-painful levels.69 Soft-tissue treatment 
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techniques are thought to influence muscular strength by altering the patient’s perception 
of pain.70  Astym® treatment has been shown to improve self-reported measures of pain 
over the course of several treatment sessions.1,5-8,10,11,16,17 However, the acute effects of 
Astym® treatment on pain have not been studied.    
 
2.2.2.1 Gate-Control Theory of Pain 
One possible mechanism of action through which soft-tissue mobilization 
techniques might influence a person’s perception of pain is the gate-control theory of 
pain.  The gate-control theory of pain is based on the principle that stimulation of larger 
diameter relatively rapidly conducting peripheral nerve fibers blocks painful stimuli 
transmitted through smaller, slow conducting neurons that enter the spinal cord at the 
same spinal level.71 Based on the gate-control theory of pain, a patient’s perception of 
pain is reduced as stimuli from small fiber nocioceptors are blocked from transmitting 
signals to central command centers in the brain by mechanical or electrical stimulation of 
larger diameter neurons from cutaneous mechanoreceptors.71 
Physical therapists commonly employ therapeutic interventions to electrically 
and/or mechanically engage the mechanisms of the gate-control theory of pain in an 
effort to reduce pain.71 A transcutaneous electrical stimulation device uses electric current 
to stimulate large fiber, cutaneous mechanoreceptors thereby blocking signals originated 
by small fiber, nocioceptors from reaching the brain and thus modulating or changing the 
perception of pain.72  Hopkins et al.73 showed that experimentally-induced pain and 
effusion to otherwise healthy knee joints resulted in decreased activation and strength of 
the quadriceps muscle group was reversed for up to 30 minutes following application of 
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transcutaneous electrical stimulation to the knee joint.73  Similarly, Pietrosimone et al.74  
demonstrated significant increases of quadriceps activation among subjects with knee 
osteoarthritis treated with transcutaneous electrical stimulation. Cetin et al.75 
demonstrated increases of isokinetic strength of the quadriceps between 50-70% from 
baseline measures following 20 minutes of transcutaneous electrical stimulation 
combined with application of a moist hot pack to the knee joint.  With the exception of 
the study performed by Pietrosimone et al.,74 the improvements in muscle performance 
coincided with a reduction of patient perceived pain that suggests therapeutic 
interventions that mediate pain have the capability to acutely change muscle activation 
and influence strength.   
2.2.2.2  Descending Pain Suppression Mechanism 
Pain suppression can also occur as unpleasant cutaneous sensations received by 
the central command centers of the brain trigger responses to inhibit the painful stimuli.  
When a painful stimulus is transmitted to the central nervous system, it stimulates nuclei 
in the midbrain.  The nuclei of the midbrain initiate activity through the descending 
spinal tracts that are returning to the spinal level in which the painful stimuli was 
received.  This stimulus causes a release of endogenous opiates at the spinal level 
receiving the painful input.70 Endogenous opiates, collectively referred to as endorphins, 
are inhibitory neurotransmitters that work to blunt the transmission of painful stimuli to 
the brain.  Endorphins are produced by the pituitary gland and hypothalamus and are 
released to the brain and spinal cord in response to pain as well as during exercise and 
elevated emotional states. Soft-tissue mobilization techniques, specifically massage 
techniques, have been shown to cause an increase of serum endorphins for up to one hour 
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following treatment.76 Based on this information, it is possible that Astym® treatment 
produces similar increases of serum endorphins that could decrease pain and result in 
improved muscle activation and performance.   
2.2.2.3  Theorized Effect of Astym Treatment on Pain Modulation 
 Astym® treatment has been shown to improve musculoskeletal sources of 
pain5,8,10,11, however, the mechanisms through which pain reduction is achieved are 
unknown.  Soft-tissue mobilization techniques are theorized to mediate pain through the 
gate-control and/or descending pain suppression mechanisms.70 Research suggests that 
reduction of pain results in a reversal of muscle inhibition that results in improved 
muscular activation and strength.69 To date, research that has investigated soft-tissue 
treatment on acute changes in muscle activity and strength has been equivocal,77-83 
however, these studies were not performed on subjects with musculoskeletal pain.  There 
is no existing study that has examined if a reduction of pain following Astym® treatment 
affects muscular activation or strength.    
 
2.2.3 Mechanosensitivity of Muscle Tissue 
Soft-tissue mobilization techniques are thought to induce changes in cellular 
functions in response to mechanical stimulation.13,14  Davidson et al.13 and Gehlsen et 
al.14 studied the effect of Astym® treatment on the cellular functions of fibroblast cells.  
Fibroblast cells are found in ligaments, tendons, and fascia and are responsible for 
producing collagen, a structural protein that gives various soft-tissues its inherent 
strength.13 The results of the research by Davidson et al.13 and Gehlsen et al.14 
demonstrated that mechanical stimulation applied through Astym® treatment resulted in a 
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significant increase of collagen production by the fibroblast cells in a rat model.13,14 
These findings were consistent with related research that has shown that mechanical 
stimulation of fibroblast cells facilitates cellular growth, increases protein synthesis, 
promotes the release of growth factors, and attracts additional fibroblast cells.84-86  
  Other types of cells are sensitive to mechanical stimulation and may be influenced 
by Astym® treatment as well.  The membranes of skeletal muscle tissue contain 
mechanosensitive ion channels that facilitate exchange of potassium and calcium ions 
necessary to propagate muscle contraction.87  Researchers have shown that increases of 
intracellular calcium within the muscle results in greater force of contraction by muscle 
fibers.88-90 Conversely, a reduction of the magnitude or rate of calcium release to working 
muscle cells results in decreased force of contraction.91 This intimate relationship of 
calcium to muscle force production is known as the force-calcium relationship.88-90 
Mechanical stimulation of various cells has been shown to increase the exchange of 
calcium ions across cellular membranes.92 Mechanical stimulation of muscle cells is 
believed to alter the concentration of calcium ions 87 that may increase force of muscle 
contraction. Whether mechanical stimulation applied through Astym® treatment affects 
the force-calcium relationship to increase muscle force production, however, has yet to be 
studied.  
 
2.2.4  Increase of blood flow 
 Astym® treatment causes a hyperemic response that can be seen on the surface of 
the skin of the body regions that have been treated.  This suggests that Astym® treatment 
results in a local increase of blood flow to the treated areas. Studies have substantiated 
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changes in blood flow as a result of other forms of soft-tissue mobilization.93-95  An 
increase of blood flow is related to physiologic changes in soft-tissue temperature that 
may enhance force output during a maximal contraction.96,97  Longworth 98 reported 
increases of tissue temperature following 6 minutes of massage that was maintained for 
10 minutes following treatment.  Drust et al.99 demonstrated increased intramuscular 
temperature of the quadriceps muscles as a response to massage.  Increased soft-tissue 
temperature can directly influence muscle strength.  Gray et al.100 found that muscle fiber 
conduction velocity is increased in muscles with an elevated temperature.  An increase of 
muscle fiber conduction velocity is strongly correlated with maximal force and rate of 
force development of a muscle.101  Based on this evidence, it is hypothesized that Astym® 
treatment may induce similar changes of blood flow resulting in increased temperature 
and potential for increased force development of the treated muscles.    
 
2.2.5  Summary of the Proposed Mechanisms for Improving Muscle 
Performance through Soft-tissue Mobilization.   
Evidence suggests that pain modulation, neuromuscular facilitation, increased 
blood flow, and increases of intracellular calcium within muscle tissue are possible 
mechanisms by which Astym® treatment may acutely increase muscle performance.  
Astym® treatment may change the perception of pain experienced by the patient.  A 
reduction of pain can result in an improved ability of the muscle to produce force. 
Astym® treatment may also stimulate neuromotor mechanisms that facilitate muscle 
contraction and force production through somatosensory stimulation.  Tactile stimulation 
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and vibration are examples of facilitatory therapeutic techniques that have been shown to 
enhance muscular strength.  Perhaps Astym® treatment could provide a similar effect to 
treated muscles through stimulation of the somatosensory system.  Astym® treatment may 
also cause changes in blood flow that increases intramuscular temperature and resultant 
muscle force production.  Finally, Astym® treatment may provide a stimulus to 
mechanically sensitive ion channels found within muscle tissues that facilitate muscle 
contraction.  These physiologic mechanisms provide a theoretical framework through 
which Astym® treatment may influence the motor system to improve muscular strength.  
A randomized, clinically controlled trial is needed to determine if Astym® treatment has 
an acute effect on muscle performance.   
 
2.3  The Effects of Therapeutic Soft-Tissue Mobilization 
Techniques on Muscle Performance 
 Therapeutic soft-tissue mobilization techniques are manual therapy interventions 
directed at soft-tissue structures to increase joint range of motion, reduce pain, decrease 
swelling, increase flexibility, or improve muscle performance. Traditionally, soft-tissue 
mobilization techniques are performed with the hands of a skilled professional, however, 
new soft-tissue mobilization techniques have evolved that utilize specialized instruments 
to assist the therapist in administering treatment. These are collectively known as 
instrument assisted soft-tissue mobilization techniques.  Research suggests that non-
instrumented and instrumented soft-tissue mobilization techniques may facilitate or 
inhibit muscle performance, depending upon the specific technique 
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employed.5,9,70,77,82,102-105   
2.3.1 Instrument Assisted Soft-Tissue Mobilization  
Many different types of instruments and methods have evolved for the purpose of 
mobilizing soft-tissue.  These techniques are known generally as instrument assisted soft-
tissue mobilization techniques.  There is limited information regarding the effects of 
instrument assisted soft-tissue techniques, specifically as it relates to muscular strength.  
The purpose of this section will be to examine patient outcomes in muscle performance 
as a result of treatment with instrument assisted soft-tissue mobilization techniques. 
Emphasis will be placed on how instrument assisted soft-tissue techniques, including 
Astym® treatment, Graston® technique, “the Stick” ®, and Foam rollers effect measures of 
muscular performance, specifically muscular strength.    
2.3.1.1 Astym® Treatment  
Improvements in muscular strength at the conclusion of care have been 
documented in studies reporting the outcomes of Astym® treatment.  In a clinically 
controlled trial, Wilson et al.17 explored the effect of Astym® treatment on patients 
diagnosed with patellar tendinopathy.  The patients were randomized into an Astym® 
treatment group or a control group.  The Astym® treatment group (6 males, 4 females) 
received Astym® treatment in addition to stretching and strengthening exercises for the 
lower extremity at a frequency of 2 times per week for 4 weeks.  The control group (5 
males, 5 females) received identical stretching and strengthening exercises 3 times per 
week for 4 weeks but did not receive Astym® treatment.  Muscle performance tests were 
utilized to determine the success of treatment.  The muscle performance tests included an 
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ability to perform: 1) 6 consecutive single limb hops, 2) a bilateral squat with thighs 
parallel to the floor, and 3) an eccentric step down test (lowering from a 10 inch step with 
the involved lower extremity) with less than a 3/10 pain by self-reported numeric pain 
scale. The results demonstrated that 100% of subjects in the Astym® treatment group 
successfully performed the muscle performance tests; while only 60% of subjects in the 
control group were able to successfully perform the muscle performance tests.17  The 
results showed that the treatment program supplemented with Astym® treatment resulted 
in superior muscle performance tests compared to a control group that performed 
stretching and strengthening exercises for the lower extremity.17   
Two case studies have also shown that Astym® treatment can influence muscle 
performance.  Haller et al. 5 documented a case of a cyclist with a 2.5 year history of 
lateral epicondylalgia.  Following 8 sessions of Astym® treatment in conjunction with 
stretching exercises, the individual’s pain score changed from a 6/10 to a 0/10 by numeric 
pain scale and her grip strength improved from 19.35 kg to 36 kg at the time of discharge 
from physical therapy.   Another case study reported by McCormack 9 documented the 
use of Astym® treatment and eccentric exercise on tendinopathy of the proximal 
attachment of the hamstring muscle group. Sixteen treatments resulted in an improvement 
of muscular strength of the hamstring muscles from a 4-/5 to a 4+/5 by manual muscle 
testing. 9   Each of these case studies demonstrated evidence of improved muscular 
performance, specifically related to measures of muscle strength, in a treatment program 
that included Astym® treatment.   However, the results from these case studies should be 
interpreted with caution.  A case study research design limits the ability to draw 
conclusions of a cause and effect relationship of the treatment intervention to the 
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outcome measures and limits the generalizability of the findings to a broader 
population.106  The addition of other components of care, specifically the inclusion of 
progressive resisted exercise in the case studies described above, limits the ability to 
attribute improvements in muscular strength to the intervention of Astym® treatment.  
Therefore, it cannot be determined with certainty that Astym® treatment was the cause of 
improved muscular strength of the patients documented in the case studies.  It also 
remains unknown if other patients with similar characteristics and complaints of 
symptoms would have the same outcome that was documented in the case studies.  To 
date, no study has specifically examined the acute effects of Astym® treatment on muscle 
strength. 
2.3.1.2  Graston® Technique  
 The Graston® technique is an instrument assisted soft-tissue mobilization 
technique that also utilizes specialized instruments to treat soft-tissue dysfunction (Figure 
2).107  The purpose of the Graston® technique differs from that described for Astym® 
treatment.  Astym® treatment is proposed to induce biological changes at a cellular level 
to promote the absorption of scar tissue and to stimulate the regeneration of soft tissues.  
The purpose of the Graston® technique is to mechanically mobilize scar tissue and 
breakdown adhesions that cause pain and limit function.107  In general the Graston® 
technique is applied more aggressively to the specific areas of soft-tissue dysfunction, 
while Astym® treatment is performed globally to the soft-tissue structures of the entire 
affected limb or body segment.    
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Figure 2.  Instruments used for application of the Graston® technique  
 
 
Despite the inherent differences in the treatment approaches of Astym® treatment 
and the Graston® technique, both techniques have similar evidence of improving patient 
outcomes.  Isolated case reports have shown that the Gratson® technique was part of a 
successful rehabilitation program in resolving symptoms of DeQuervain’s 
tenosynovitis,108 compression fracture of the lumbar spine,109 plantar fasciitis,107,110,111 
lateral epicondylagia,112 Achilles tendinopathy,113,114 and arthrofibrosis of the knee.102  
Although these case reports demonstrate improvements in pain and self-reported 
functional scores, few of these cases have reported changes in muscular strength.  In a 
case describing the outcome of a patient with arthrofibrosis following surgical repair of 
the quadriceps tendon, Black 102 showed that quadriceps muscle performance as measured 
by an extension lag during a straight leg raise maneuver, improved following a treatment 
program consisting of the Graston® technique as well as joint mobilization and 
strengthening exercises.  Use of the Graston® technique with stretching and strengthening 
exercises in the management of a 35 year-old female with a 2-year history of chronic calf 
pain also resulted in modest changes in muscle performance.115  Improvements of 
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plantarflexion strength from 4/5 by manual muscle test to 5/5 were documented over the 
course of 9 treatment sessions.  She also improved her ability to perform single-limb 
heel-raises from 22 repetitions to 25 repetitions.   A cause and effect relationship, 
however, cannot be concluded from a case study research design and thus it remains 
uncertain how much the Graston® technique can influence muscular strength. 
2.3.1.3 “The Stick” ® 
 “The Stick” ® is described as a non-motorized massage device composed of a 24-
inch rod around which several individual 1-inch cylinders rotate (Figure 3). The 
instrument is intended for patients to self-administer treatment by rolling the device over 
the affected areas of perceived pain or dysfunction.103  Mikesky et al.103 studied the use of 
“the Stick” ® on muscle strength, power, and flexibility.  In this randomized, double blind 
study, 30 collegiate athletes were recruited to participate and were exposed to three 
different treatment protocols: a control group that received no treatment, a placebo group 
that received mock electrical stimulation (electrodes placed on the leg, but never turned 
on), and a treatment group using “the Stick” ® on the muscles of the lower extremity for a 
total of 2 minutes.  Four tests were performed immediately following the designated 
treatment to represent different components of muscle performance:  1) peak torque 
generated during isokinetic knee extension set at 90°/second, 2) a vertical jump test, 3) 
timed speed during a 20-yard sprint, and 4) angle of flexion of the hip joint while 
performing an active straight leg raise (maximum flexion angle of the hip joint with the 
knee extended and ankle in neutral dorsiflexion).  The order in which the tests were 
administered was standardized for each testing session: 1) flexibility, 2) vertical jump, 3) 
20-yard sprint, and 4) isokinetic strength.  The subjects were asked to attend 3 separate 
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treatment sessions spaced a week apart.  A different treatment protocol was performed 
each week so that by the end of the 3 weeks, each subject was exposed to each of the 
three treatment protocols (control, placebo, and “the Stick” ®). At the conclusion of every 
weekly treatment session, the measures of muscle performance were performed.  The 
researchers compared the results of the measures of muscle performance for each of the 
treatment protocols using a one-way analysis of variance.  The statistical analysis showed 
that none of the treatment conditions, including use of “the Stick” ®, resulted in a 
significant difference in the measures of muscle performance.103  The researchers 
concluded that use of “the Stick” ® had no impact on facilitating improvements in muscle 
performance.   
 
Figure 3.  “the Stick” ® 
2.3.1.4  Foam roller 
 The foam roller has become an increasingly more common tool for patients to 
self-administer soft-tissue treatment (Figure 4).  Abels et al.116 studied the effects of self-
administered soft-tissue treatment using a foam roller on muscle performance.  A 2.5-
minute foam roller protocol to the muscles of the lower limb was followed by the drop-
jump test.  The researchers compared maximal vertical height displacement and 
magnitude of the soleus reflex in the limb that received treatment to the limb that did not 
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receive treatment.  The results showed that the foam roller intervention did not have a 
statistically significant effect on vertical height displacement (p=0.525) and latency of the 
soleus reflex of the limb (p=0.693) when compared to the limb that did not receive the 
foam roller treatment.116  Sullivan et al.117 noted improved performance of flexibility 
measures with use of a foam roller protocol that did not influence maximal muscular 
force production or electromyography of the treated muscles.  Healey et al.118 showed 
that a foam roller protocol affected self-perceived post-exercise fatigue but did not have 
an impact on muscular performance as noted on a vertical jump test, isometric squat force 
production, and speed on the Pro agility test.  Collectively, much of the literature on soft-
tissue mobilization using self-administered techniques with a foam roller has 
demonstrated the capability to improve flexibility while having no significant effect on 
acute muscle performance, specifically in regards to muscular strength.  
 
Figure 4.  Self-administered treatment of the lower extremity using a Foam Roller 
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2.3.1.5  Summary of the effects of Instrument Assisted Soft Tissue Mobilization on 
Muscle Performance  
 There is limited evidence to make definitive conclusions regarding the effect of 
instrument assisted soft-tissue mobilization on muscle performance.  Improved measures 
of lower extremity muscle performance was found in one randomized clinical trial that 
investigated the effect of a series of Astym® treatments compared to a control group that 
received treatments of stretching and strengthening exercises.17  Case studies 
documenting the effect of Astym® treatment and Graston® technique have shown modest 
improvements in muscle performance.102,115  However, clinical trials that examined self-
administered techniques including those utilizing “the Stick” ® or foam rollers have 
shown inhibitory or equivocal effects in measures of muscle performance.103,117,118   The 
conflicting results from the existing literature make it unclear as to how instrument 
assisted soft-tissue mobilization techniques affect muscle performance.   
2.3.2  Non-Instrumented Soft-tissue Mobilization 
 Non-instrumented soft-tissue mobilization techniques can be defined as 
therapeutic mobilization techniques applied with the skilled hands of a trained 
professional for the purpose of treating pain, swelling, limited flexibility, or impaired 
muscle performance that limits the functional abilities of an individual.  There are many 
types of non-instrumented mobilization techniques used to treat soft-tissue dysfunction, 
the most common being therapeutic massage techniques. The purpose of this section will 
be to explore the scientific literature that exists regarding the influence of the different 
types of massage and other non-instrumented soft-tissue techniques on muscle 
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performance, specifically muscular strength. 
2.3.2.1  Types of Massage Techniques 
There are many types of massage techniques used to treat soft-tissue 
dysfunction.119  The most common techniques reported in the literature include 
effleurage, petrissage, deep transverse friction massage, and tapotement.119,120  Effleurage 
consists of light or gentle stroking techniques performed longitudinally along the length 
of a muscle or body segment.119,121  This technique is usually performed in a distal to 
proximal direction and is commonly used to sooth, relax, or comfort a patient in between 
more aggressive or vigorous types of massage.119,121  Petrissage is an example of a more 
aggressive type of massage technique that incorporates kneading, wringing or scooping 
strokes to the soft-tissue.119,121  Petrissage techniques are generally performed more 
vigorously and more rapidly than effleurage techniques with deeper pressure 
administered to the underlying muscular tissues. 119,121  Deep transverse friction massage 
is described as a penetrating massage technique that targets tissues deep to the 
hypodermis including muscle, ligaments, and tendons.  Deep transverse friction massage 
is generally performed with small vigorous strokes applied through the fingertips, 
perpendicular to the fiber alignment of the target tissue.  This technique is designed to 
induce mild tissue destruction characterized by hyperaemia and an inflammatory reaction 
with the intent to reduce adherent or contracted tissue and induce tissue 
remodeling.119,121,122 Tapotement refers to percussive massage techniques that may 
include tapping, striking, or clapping on the recipient’s body.  The purpose of tapotement 
techniques is to cause vasodilation and trigger cutaneous reflexes that are believed to 
increase muscular tone.121  
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2.3.2.2  Effect of Massage on Muscle Performance  
Several studies have investigated the effect of massage on muscle performance. 
The majority of evidence suggests equivocal and potential negative influence of massage 
on muscle performance.  Arroyo-Morales et al. 77 studied the effects of a combination of a 
20-minute massage session consisting of effleurage, petrissage, and tapotement 
administered to the gastrocnemius-soleus muscle complex, hamstrings, and quadriceps 
muscles on the isokinetic peak torque of knee flexor and extensor muscles.  The study 
found that isokinetic peak torque output of the knee extensor muscles was significantly 
reduced immediately following massage treatment compared to a placebo treatment when 
tested at isokinetic speeds of 240°/second and 180°/second.  There were no statistical 
differences noted between the placebo and massage treatment groups for isokinetic peak 
torque output of the knee extensor muscles at 60°/second, 120°/second nor were there 
statistical difference in isokinetic peak torque of the knee flexor muscles at any of the 
tested speeds (60°/second, 120°/second, 180°/second, 240°/second).77  Wiktorsson-
Moller et al. 82 reported similar effects of massage on isokinetic and isometric peak torque 
of the knee extensor and flexor muscles.  A significant decrease in isokinetic peak force 
of the knee flexor muscles at isokinetic speeds of 30°/second and 180°/second and 
decreased isometric peak force for the knee extensor muscle group were observed 
following an average of 12 minutes of petrissage to the lower limb.  McKechnie et al. 80 
compared the peak torque of the plantarflexor muscle group between three different 
massage treatment groups.  The first group received 3 minutes of petrissage treatment to 
the gastrocnemius-soleus muscle complex.  The second group received 6 minutes of 
tapotement treatment to the gastrocnemius-soleus muscle complex.  The third group 
 38 
received a placebo treatment to the gastrocnemius-soleus muscle complex.  The results 
showed that peak torque did not demonstrate a significant difference for either of the 
massage treatment groups compared to the placebo.80 Similar results have been reported 
in studies using massage protocols that included 8-30 minutes of petrissage and 
effleurage treatment. These studies failed to demonstrate improvements in variables of 
muscle performance including power and peak torque.78,79,81,123,124 Arazi et al.104 studied 
the effect of a 15-minute swiss massage protocol to both of the lower limbs that included 
components of effleurage, petrissage, tapotement, and vibration on vertical jump, agility, 
and sprint performance.  Using a pre-test/post-test design, the results showed that vertical 
jump, agility, and sprint performance significantly decreased immediately following 
massage treatment.  Mancinelli et al. 125 also demonstrated decreased performance in 
agility testing with a 17-minute massage protocol consisting of effleurage, petrissage, and 
vibration techniques.  However, vertical jump performance demonstrated a statistically 
significant improvement.125 
There are only a few clinical trials that have shown an improvement of muscular 
performance following massage treatment.  According to Micklewright et al.,126 a 30-
minute massage treatment that included effleurage and petrissage techniques significantly 
improved anaerobic power as determined by the Wingate Anaerobic Cycling Test when 
compared to a control group that did not receive massage treatment. In a similar study, 
Ogai et al. 127 demonstrated increased total power of cycling following a 10-minute 
petrissage treatment to the lower extremity compared to a control group that did not 
receive treatment.  A 3.1% improvement of performance was noted in the massage group 
compared to a 0.8% decrease of performance in the control group.   In a similar study, 
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Brooks et al.16 investigated the effect of massage on grip strength after fatiguing exercise 
Subjects were randomized into a massage group, a passive range of motion group, and a 
control group that received no treatment.  The subjects in the massage group received 5-
minutes of effleurage and cross-friction massage to the hand and forearm. A comparison 
of the groups showed that the massage group yielded a significantly greater increase of 
grip strength when compared to subjects that received passive range of motion or no 
treatment at all. The authors concluded that stimulation of available motor units, an 
analgesic effect, and a perceived recovery effect experienced by the subjects resulted in 
improved muscular strength.128  
 The majority of evidence on massage and muscle performance suggests that 
massage has a negative influence on muscle strength and power.  With the exception of 
the study performed by Brooks et al.,128 massage has shown little value in recovery of 
strength following muscle fatigue.78,79,81,123,124,129,130 Analysis of the literature should 
consider the methods of massage employed by these studies.  The majority of the articles 
reviewed utilized protocols of massage of varying techniques and times.  Most of the 
techniques incorporated effleurage and petrissage.  These specific massage techniques are 
proposed to have inhibitory effects on the excitability of motorneurons.105  Tapotement 
techniques, however, are believed to have an excitatory effect on motor neurons.  
McKechnie et al.80 provided a study that compared a group that was treated with a 
massage protocol consisting of only tapotement techniques compared to a group that 
received petrissage techniques.  If tapotement techniques do provide an excitatory effect 
on motor neurons, then it was not enough to elicit significantly greater production of peak 
torque in the plantarflexor muscles of the ankle when compared to a group that received 
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petrissage treatment.80  The collective findings from studies on the effect of massage on 
muscular strength suggest that massage does not result in an increase of muscular 
strength.   
2.3.2.3 Active Release Therapy® 
 Active Release Therapy® is a non-instrumented soft-tissue mobilization technique 
that uses sustained longitudinal manipulation of soft tissue in cooperation with active and 
passive motion of the individual’s body.131  Active Release Therapy® is indicated in the 
treatment of various soft-tissue disorders, including shin splints, sciatica, carpal tunnel 
syndrome, plantar fasciitis, and tendinopathy.83  Because Active Release Therapy® 
involves conscious activation of muscle tissue by the patient, it is believed to directly 
affect muscle performance.131.  Drover et al.83 studied the effect of Active Release 
Therapy® on the maximal force production of the quadriceps muscle group.  The results 
demonstrated that Active Release Therapy® did not have a significant effect to either 
increase or decrease force production of the quadriceps muscle group.  Although Active 
Release Therapy® requires conscious muscle activation by the individual, the techniques 
also place the muscle tissues in a lengthened position that stretches the muscles.131  
Stretching of muscle tissue has been shown to cause a decrease in muscle performance, 
specifically measures of muscular strength.132-136  Based on the results described by 
Drover et al.,83 it may be concluded that any facilitory effect elicited by stimulation of the 
somatosensory system during Active Release Therapy® is negated by an inhibitory effect 
caused by lengthening and stretching of the muscle tissue.  
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2.3.2.4 Summary of Non-Instrumented Soft-Tissue Mobilization Techniques 
 The majority of evidence presented on non-instrumented soft-tissue mobilization 
techniques suggests a negative or equivocal effect on muscle performance.  The evidence 
from clinically controlled trials studying various types of massage techniques indicates a 
negative impact on multiple measures of muscle performance.78,79,81,123,124  Active 
Release Therapy® combines soft-tissue mobilization with active and passive lengthening 
of the treated tissues.  A clinically controlled trial demonstrated no significant change in 
muscle performance as a result of Active Release Therapy®.83   The summary of the 
literature suggests that, depending on the technique used, non-instrumented soft-tissue 
mobilization has a negative or equivocal influence on muscle performance. 
 
2.3.3 Comparing Astym® Treatment to Other Therapeutic Soft-Tissue 
Mobilization Techniques  
 Based on the review of therapeutic soft-tissue mobilization techniques, it remains 
unclear how Astym® treatment will influence muscular strength.  There are conflicting 
results presented in the existing literature on the effect of soft-tissue mobilization 
techniques on muscle strength.  The contradictory findings may be explained by the 
differences between the specific techniques.  
 The use of Astym® instruments may enable greater pressure to be applied to the 
tissues during treatment. Gehlsen et al.14 found that measures of fibroblast cell function 
were greatest for the treatment condition in which the greatest amount of pressure was 
applied through the Astym® instruments during treatment.  Although the effect of 
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pressure applied with the Astym® instruments has yet to be studied on muscle tissue, 
research presented by Kukulka et al.137 reported a 10-15% increase of motorneuron 
excitability in response to deep pressure applied to the muscle belly. Astym® treatment 
and the Graston® technique both use hand-held instruments to administer deep pressure to 
the targeted treatment areas.  Although the strength of the evidence is weak, the existing 
evidence suggests that the Graston® technique 102,115 and Astym® treatment 5,9,17 have a 
positive influence on muscle strength, whereas soft-tissue mobilization techniques that 
require less treatment pressure, such as effleurage and petrissage, have an equivocal or 
inhibitory effect on muscle performance.77,78,81,82,123,124.  Differences in the pressures used 
for these techniques may explain the contradictory findings.   
The speed of which the soft-tissue mobilization is administered may also have an 
influence on muscular strength. The strokes applied with the Astym® instruments are 
administered at an approximate rate of 6-8 inches per second. 12  This provides a faster 
pace of soft-tissue mobilization compared to the techniques described for effleurage, 
petrissage, foam roller, “the Stick”, and active release therapy that are performed with 
slower strokes and were found to have an equivocal or inhibitory effect on muscle 
strength.77,78,80,82,83,103,116,123,124  Goats121 suggests that the speed in which massage strokes 
are administered can influence whether an excitatory or inhibitory effect on muscle 
contraction is produced.  Quicker, more vigorous strokes are believed to be excitatory 
while slower strokes are thought to be inhibitory to muscle contraction.121  Slower 
massage strokes and techniques are also thought to stimulate the parasympathetic nervous 
system.  Stimulation of the parasympathetic nervous system will lower heart rate and 
blood pressure and promote muscle relaxation.30 Fast and vigorous cutaneous stimulation, 
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conversely, stimulates the sympathetic nervous system and promotes muscle excitation.30 
In contrast to effleurage, petrissage, foam roller, “the Stick” ®, and Active Release 
Therapy® techniques, Astym® treatment may act to stimulate the sympathetic nervous 
system, resulting in a short-term improvement of muscle performance.   
Astym® treatment also differs from other soft-tissue mobilization techniques in 
that the treatment is administered to the entire limb or body segment.12 As a result, 
Astym® treatment may stimulate a broader range of muscles, including agonist muscle 
groups found within the kinetic chain. With the exception of massage, none of the other 
soft-tissue mobilization techniques described are used to treat regions other than the 
specific area of pain or injury.  It is possible that a more global approach in treatment 
may result in enhanced recruitment of muscle groups that ultimately increase measures of 
muscular strength.   
The acute effects of Astym® treatment on muscle strength remain unclear.  There 
are unique aspects of Astym® treatment that are different from other soft-tissue 
mobilization techniques that may initiate physiological mechanisms to enhance muscular 
strength. Astym® treatment is performed with generally greater pressure, speed, and a 
globally wider area of treatment compared to other soft-tissue mobilization techniques.  
These factors are believed to have a positive influence on muscular strength, but must be 
further explored in a clinically controlled trial that investigates the effects of Astym® 
treatment on muscular strength. 
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Chapter 3 
  
 
Methods 
 
 
3.1 Experimental Design  
  A double-blinded, repeated measures design was used to investigate the effect of 
Astym® treatment on acute muscular strength of the lower extremity. The dependent 
variable of interest was the maximal force generated during a unilateral isometric squat 
test.  The independent variable of interest was the treatment received by the subjects:  1) 
Astym Treatment - received a lower extremity Astym® treatment 2) Control-received no 
treatment; 3) Placebo-received a sham Astym® treatment.  Subjects were randomly 
assigned to receive the control, placebo, or Astym® treatment intervention and were 
blinded to the treatment of their assigned group.  The primary investigator (brk) 
performed the control, placebo, or Astym® treatment interventions.  A second 
investigator (lb), blinded to the treatment, administered the pre- and post-treatment 
isometric squat tests.  Both investigators remained blinded to the results of the isometric 
squat tests until the post-treatment tests were completed for all subjects.   
 
3.2 Subjects 
 A total of 45 subjects between the ages of 18 to 65 years that met the 
inclusion/exclusion criteria were recruited from the outpatient facilities of Tri-State 
Physical Therapy, Seven Fields, Pennsylvania.  Sample size estimates were projected 
 46 
based on data from a pilot study (see section 3.6).  Potential subjects were informed of 
the study by front office staff of Tri-State Physical Therapy during the subject’s first 
appointment and presented the individual with an informational flyer highlighting the 
purpose and procedures of the study.  Recruitment of subjects continued until each group 
had 15 subjects.  
 Selection criteria for subjects included: 1) males or females aged between 18-65 
years, 2) a referral from a medical doctor for physical therapy services for a 
musculoskeletal injury/condition to the lower extremity, and 3) no complaints of bilateral 
symptoms to the lower extremities.  Exclusion criteria included: 1) medical history of 
hemophelia or other clotting disorders of the blood; 2) medical history of cardiovascular 
disease including those with previous cardiovascular surgery and uncontrolled 
hypertension; 3) current use of prescription blood thinners (e.g. Lovenox, Coumadin); 4) 
a history of metastatic disease; 5) neuropathy of the lower extremity; 6) current 
complaints of lumbar or shoulder symptoms; and 7) an active infection (or taking 
medication for an infection).  All subjects were asked to read and sign an informed 
consent form approved by the Duquesne University Institutional Review Board and to 
complete the Lower Extremity Functional Scale to objectify functional limitations caused 
by their condition.  Subjects that scored below a score of 40 or above a score of 70 points 
out of a possible 80 points on the Lower Extremity Functional Scale were excluded from 
the study. Once subjects consented to the study and completed study-related paper work 
they performed strength testing as described under procedures (section 3.4). Subjects 
with less than a 10% deficit in maximum force output during an isometric squat test when 
compared to the uninvolved side were excluded from further testing. Testing during a 
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pilot study determined that less than 10% of subjects with a musculoskeletal pathology of 
the lower extremity do not have a strength deficit as determined by an isometric squat test. 
Subjects that did not tolerate the Astym® treatment as described in the procedures were 
also excluded from the study. Data from a pilot study determined that less than 1% of 
subjects do not tolerate Astym® treatment. 
 
3.3 Instrumentation 
 Maximum force output during an isometric squat test was measured using a 
computerized leg press machine (Figure 5) equipped with a load cell (CDM Sport; Fort 
Worth, TX).  The load cell was tested by the manufacturer and demonstrated less than 
0.02% error for repeatability, zero balance, creep, non-linearity and hysteresis.138 Data 
from a pilot study demonstrated excellent criterion validity for the computerized leg press 
machine to a digital force dynamometer with a Pearson correlation coefficient of 0.99. 
The analysis revealed the Typical Error of the Estimate to be 10.69 Newtons (95% CI: 
8.13-15.62 Newtons).  A detailed description of the testing performed during a pilot study 
to establish validity of the measurement is found in Appendix A.   Measurement of force 
production during an isometric squat test has demonstrated test-retest reliably of 0.97.139  
However, there is no published literature documenting the reliability of the specific 
computerized leg machine used in this study. An investigation during a pilot study to 
establish the test-retest reliability of the computerized leg press machine is presented in 
Appendix B.  An intra-class correlation coefficient of 0.99 indicated excellent test-retest 
reliability of the computerized leg press machine used in this study. The standard error of 
the measurement was determined to be 2.7% change with a minimal detectable change of 
7.5% change. 
 48 
 
 
Figure 5.  Patient performing a maximal isometric squat test on the Monitored Rehab 
Systems Computerized Leg Press Machine. 
 
3.4 Procedures 
 All procedures were identical for each subject.  Demographic information was 
collected including age, height, weight, gender, lower extremity-dominance, and 
musculoskeletal diagnosis as determined by assimilation of a physician prescription and 
office notes, current subjective complaints/symptoms, and objective findings from 
physical therapy examination.  Subjects filled out a medical history form that included 
items specific to the exclusion criteria.  The subjects also filled out a self-reported 
functional questionnaire containing the numeric pain scale (0-10) and the Lower 
Extremity Functional Scale.  The numeric pain scale and Lower Extremity Functional 
Scale are commonly used in research and clinical settings to assess a patient’s severity of 
pain and the functional impact of their injury to the lower extremity.140,141 The numeric 
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pain scale has demonstrated adequate test-retest reliability (r=0.63) 142 and established a 
minimal detectable change of 3 points.143 The Lower Extremity Functional Scale has 
demonstrated test-retest reliability of r=0.94, construct validity to the Short Form-36 
physical function score (r=0.80), and a minimal detectable change of 9 points.140 Once 
the subject completed the forms, they were asked to ‘warm-up’ by cycling at a self-
selected pace on a lower body ergometer (Sports Art c530 Lower Body Ergometer, 
Woodinville, WA) for five minutes.    
Next, maximum isometric force during a squat test was measured for each lower 
extremity using a computerized leg press machine (CDM Sport; Fort Worth, TX). The 
lower extremity that was tested first was randomly selected for each subject by a coin 
flip.  The leg press was adjusted for the designated lower extremity such that the subject’s 
knee joint was placed and maintained at 70° of knee flexion as determined by a standard 
8-inch goniometer (AliMed 5055 - Med. International Standard 8-in. Goniometer, 
Dedham, MA).  The test-retest reliability for goniometry of the knee joint has been 
reported at r=0.80.144  Foot position was standardized on the footplate of the leg press so 
that the bisection of the foot, ankle, and hip joints are in alignment in the sagittal plane 
and the crest of the tibia is parallel to the floor.  A testing protocol as described by Carcia 
et al.138 was utilized to collect maximum force output during the isometric squat test.  The 
subjects were asked to push through their heel against the footplate of the leg press a total 
of five times. The first repetition was performed at approximately 50% effort, the second 
at 75% effort, and the remaining three repetitions at 100% effort.  The average of the 
maximum force output (Newtons) produced during the final three trials was used to 
represent the subject’s maximal force output during an isometric squat test. An 
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investigation during a pilot study performed prior to the initiation of this research study 
demonstrated no evidence of a learning or fatigue effect utilizing a 1:10 work/rest ratio 
over ten consecutive trials on the same lower extremity (Appendix C).  Pain was 
monitored before and after isometric testing using the numeric pain scale. Once the 
testing had been completed on the designated lower extremity, the opposite lower 
extremity was tested using the same testing procedures.  Subjects that did not 
demonstrate greater than a 10% deficit of the involved side compared to the uninvolved 
side were not considered to have a significant strength deficit caused by their injury and 
were dismissed from the study. 
Next the subjects were randomly assigned to the control, placebo, or treatment 
group.  Random assignment to the groups was determined using a random numbers 
generator (http://www.graphpad.com/quickcalcs/index.cfm) to create three equal groups 
of 15 subjects.  The treatment group received Astym® treatment to the muscles of the 
anterior and lateral compartments of the leg, the gastrocnemius/soleus muscle complex, 
the quadriceps muscle group, the hamstrings muscle group, the gluteus maximus, and the 
gluteus medius muscles on the involved side as described by the Astym® Clinical 
Manual.12  This technique includes two sets of strokes that were performed with the 
Astym® instruments in both proximal to distal and distal to proximal directions. A set of 
strokes covered the entire width and length of the muscle groups mentioned above from 
origin to insertion.  The Astym® treatment was performed as the edge of the instruments 
indirectly contacted the fascial and musculotendinous tissues deep to the skin and 
subcutaneous tissue.  The indirect contact of the instruments with the underlying fascial 
and musculotendinous tissues present with a discernable texture that is different from the 
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texture appreciated from contacting only the skin and superficial fascia.12  The difference 
in the texture that can be appreciated by the therapist determines the appropriate amount 
of pressure applied through the instruments to mechanically stimulate the targeted 
underlying soft-tissue structures.12  Individuals that are lean require less pressure through 
the instruments to indirectly contact the ligamentous, deep fascial, muscular, and 
tendinous tissues that are deep to the superficial fascia.12  Because each individual 
possess a different amount of adipose tissue within the superficial fascia, the exact 
amount of pressure applied through the instruments varies according to each individual’s 
body composition.  However, indirect contact of the instruments with the muscle, tendon, 
deep fascia, and ligamentous tissues as determined by the unique texture that these 
structures provide remains consistent regardless of body composition of an individual.  
Therefore, each Astym® treatment provides a consistent stimulation of the muscle, 
tendon, deep fascia, and ligamentous structures despite variability in body composition 
between individuals. The speed of the strokes over the musculotendinous structures was 
consistent at 6 inches/per second. 12  The investigator performing the Astym® treatment 
(brk) has been certified in the technique and has over 3 years experience administering 
the technique for lower extremity musculoskeletal dysfunction.  Although the treatment is 
not intended to be painful, the investigator monitored the subject’s comfort level during 
treatment with a post-treatment numeric pain scale rating.  Pain that exceeded a 7/10 on 
the numeric pain scale or any verbal or non-verbal indication by the subject that 
suggested they were not comfortable with the treatment resulted in an immediate 
termination of the treatment and the subject was withdrawn from the study.   
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The control group did not receive any treatment and was asked to sit on a 
treatment table for 12 minutes. Twelve minutes represented the average time it took to 
perform an Astym® treatment to the lower extremity as determined during a pilot study.   
The placebo group received a sham Astym® treatment.  The sham treatment was 
analogous to an effleurage massage with the Astym® instruments.  The sham treatment 
differed from the actual Astym® treatment only in the pressure administered by the 
investigator and the treatment-edge of the instrument used to administer the treatment 
(Figure 6).  The primary investigator (brk) glided the non-treatment edge of the Astym® 
instruments over the skin of each of the treatment areas previously described for the 
Astym® treatment group. Pressure through the instruments was light enough to avoid the 
texture felt through indirect contact of the fascial and musculotendinous structures deep 
to the subcutaneous layer with the Astym® instruments.  The direction, number of 
strokes, and speed of the strokes remained consistent with that previously described for 
the Astym® treatment group and continued for approximately 12 minutes.   
Α   Β  
Figure 6.  Treatment edge used for the A) Astym® treatment versus  
 the B) Sham treatment.   
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Once the designated treatment intervention was completed, the subject was 
retested on the computerized leg press machine using the identical testing procedures as 
described above.  A second investigator (lb) blinded to the type of treatment the subject 
received administered the isometric squat tests.  The investigator performing the Astym® 
treatment did not have access to test results until testing was completed for each subject.  
Once the post-test was complete the subject satisfied the obligations of the research study 
and resumed the normal course of his/her care as determined by the physical therapist.  
 
3.5 Statistical Analysis 
 All data was entered into SPSS Version 20 (SPSS Inc.; Chicago, IL) for statistical 
analysis. Descriptive statistics (means /standard deviations/range) of age, height, weight, 
self-reported functional score, pre-treatment pain rating, and post-treatment pain rating of 
the subjects was reported and compared between groups with an analysis of variance.     
The frequency of gender and the medical diagnoses by type (musculotendinous versus 
non-contractile) and region (proximal portion of the lower limb versus distal portion of 
the lower limb) for each respective treatment group was compared using a chi-square 
analysis. The percent change of maximum force output from pre-test to post-test was 
calculated by the following formula: 
 
Post-Test  -  Pre-Test 
          Pre-test                X 100 = Percent Change 
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The mean of the percent change for each group (Control, Placebo, Astym® 
treatment) was compared using a one-way analysis of variance with a predetermined 
alpha set at 0.05. A Tukey’s post-hoc analysis was then used to determine which groups 
were statistically different from each other.   
 
3.6 Power Analysis 
 Data from a pilot study were collected to determine an appropriate sample size for 
this research project.  Using the data collection procedures described above, the percent 
change of maximum force output was collected for 12 volunteers that received the 
control treatment, 12 volunteers that received the placebo treatment, and 12 volunteers 
that received the Astym® treatment.  The mean and standard deviation of the percent 
change of maximum force output from each group is presented in Table 2.  The data were 
used to determine the mean difference and the effect size of the control and placebo 
groups to the treatment group. The mean differences and effect sizes are presented in 
Table 3. A commercially available power analysis software program (JMP Pro 10; Cary, 
North Carolina) was used to calculate the sample size needed to obtain 80% power with 
alpha set at 0.05 based on the smallest effect size (Astym®-Control) determined from the 
pilot study data.  The results of the power analysis concluded that a sample size of 15 
subjects per group was needed to detect a minimal difference of 14% between the groups. 
The results of the pilot study testing also demonstrated that 20% of prospective subjects 
did not meet the exclusion criteria and less than 1% of subjects did not to tolerate the 
Astym® treatment.  Based on this estimate, we anticipated that a total of 54 subjects 
would be needed to meet the required minimum of 15 subjects per group.  
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Table 2.  Pilot Study Data:  Mean and standard deviation of the percent change of 
maximum force output according to treatment group. 
Group Number of Subjects  Mean % Change Standard Deviation 
Astym® 12 19 17 
Placebo 12 1 10 
Control 12 5 9 
 
 
 
Table 3.  Pilot Study Data:  Mean differences and effect size of group comparisons. 
 
Group Mean Difference Effect Size  
Astym® - Placebo 18% 0.54 
Astym® - Control 14% 0.46 
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Chapter 4 
 
 
Results 
 
4.1  Subjects 
 
 A total of 59 subjects enrolled in the study.  There were 14 subjects that did not 
meet the exclusion criteria. A flow diagram of the subjects enrolled in the study is 
represented in Figure 7.  Ten subjects were excluded from the study because they did not 
exhibit a 10% strength deficit of the involved side compared to the uninvolved side, 2 
subjects scored greater than 70 points on the Lower Extremity Functional Score, 1 subject 
had a medical history of low back pain within the past 6 months, and 1 subject was taking 
medication for an infection that excluded them from participating in the study.   
 
Figure 7.   Flow diagram of the subjects enrolled in the study. 
 
Assessed for Eligilbility 
(n=59)
Excluded
(n=14)
> 70 points on Lower 
Extremity Functional Score
(n=2)
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(n= 10)
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(n=1)
Infection (n=1)
Met Inclusion/Exclusion 
Criteria
(n=45)
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Astym Treatment Group (n= 
15)
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(n= 15)
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(n= 15)
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 Data were collected on a total of 45 subjects.  The average age, height, weight, 
self-reported functional score, pre-treatment pain rating, post-treatment pain rating, and 
involved side to uninvolved side strength deficit is reported according to each respective 
treatment group in Table 4.  The analyses of variance demonstrated no statistical 
difference between the treatment groups for age (p=0.19), height (p=0.60), 
weight(p=0.72), self-reported functional score(p=0.99), pre-treatment pain 
rating(p=0.85), post-treatment pain rating(p=0.08), and involved side versus uninvolved 
side strength deficit (p=0.56).  Gender, lower extremity dominance, and involved side 
ratios of the subjects are also organized according to treatment group in Table 4.  A chi-
square analysis demonstrated no significant difference in the female to male 
ratio(p=0.48), lower extremity dominance ratio(p=0.76), or involved side ratio(p=0.77) 
for the subjects between the three treatment groups.  Diagnoses were also not statistically 
different between treatment groups according to the region (distal or proximal; p=0.71) 
and type(musculotendinous or non-contractile; p=0.69) (Table 5).  The frequency of 
gender, lower extremity dominance, and diagnosis of the subjects according to treatment 
group is reported in Appendix D.   
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Table 4.  Mean and standard deviation of age, height, weight, self-reported functional 
score, pre-treatment pain rating, post-treatment pain, and involved side to uninvolved side 
strength deficit according to treatment group. 
 
 Astym® 
(mean+SD) 
Placebo 
(mean+SD) 
Control  
(mean+SD) 
TOTAL 
(mean+SD) 
Age (years) 42+12 43+13 35+12 40+13 
Height (cm) 166+13 168+12 170+9 168+11 
Weight (kg) 68+11 70+14 75+20 71+15 
Functional score (0-80 points) 60+10 60+9 60+8 60+9 
Pre-treatment Pain Rating  
(0-10) 
2+2 2+2 3+2 2+2 
Post-treatment Pain Rating  
(0-10) 
2+2 3+2 3+2 3+2 
Gender (Females:Males) 4:1 3:2 2:1 31:14 
Lower Extremity Dominance 
(Right:Left) 
14:1 13:2 14:1 41:4 
Involved Side (Right:Left) 3:2 7:8 8:7 24:21 
SD = standard deviation.  
 
Table 5.  Frequency of Diagnoses by Region and Type According to Treatment Group. 
 
 Astym® Placebo Control TOTAL 
Diagnosis by Region     
      Hip 2 0 2 4 
      Thigh 2 6 3 11 
      Knee 6 6 6 24 
  PROXIMAL TOTAL 10 12 11 33 
      Leg 0 1 0 1 
      Ankle 3 0 2 5 
      Foot 2 2 2 6 
  DISTAL TOTAL 5 3 4 12 
Diagnosis by Type     
         Musculotendinous 5 5 7 17 
         Non-Contractile   10 10 8 28 
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4.2  Statistical Results 
 
 A one-way analysis of variance was conducted to explore the effect of Astym® 
treatment on maximal force output by comparing a percent change in the maximal force 
output among subjects that received an Astym® treatment, control treatment, or a placebo 
treatment.  There was a significant effect of the percent change of maximal force output 
at the p<0.05 level for the Astym®, placebo, and control treatment groups [F(2,42) = 
7.91, p = 0.001].  The partial eta-squared calculated to determine effect size was η2 =0.27.  
Tukey’s post hoc analysis showed that the percent change of maximal force output was 
significantly greater in the Astym® group that improved from 994 Newtons to 1150 
Newtons (15+18%change) compared to the placebo group that decreased from 965 
Newtons to 918 Newtons (-6+11%change) and the control group that decreased from 
1043 Newtons to 972 Newtons (-1+17%change).  No significant difference was noted 
between the control and placebo groups (p=0.68).  Table 6 summarizes the analysis of 
variance.  Table 7 presents the mean and standard deviation of the percent change of 
maximum force output according to treatment group and Table 8 compares the mean 
differences and the level of significance (p-value) between each of the group 
comparisons.   The raw data describing age, height, weight, Lower Extremity Functional 
Score, involved versus uninvolved strength deficit, pre and post-treatment pain levels, 
pre-treatment force output, post-treatment force output, and percent change in force 
output is reported in Appendix E.   
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Table 6.  Summary table for analysis of variance for percent change in maximal force 
output (Newtons). 
Source df Sum of 
Squares 
Mean Square F p η2 
Between 
Groups 
2 3902.53 1951.27 7.91 0.001 0.27 
Within Groups 42 10366.28 246.82    
TOTAL 44 14268.80     
 
Table 7.  Mean, standard deviation, and range of the pre-treatment force output, post-
treatment force output, and percent change of maximum force output according to 
treatment group. 
Group Pre-treatment Force 
Output (Newtons) 
Post-Treatment Force 
Output (Newtons) 
Percent Change in 
Force Output (%) 
Mean SD Range Mean SD Range Mean SD Range 
Astym 994 527 354-
2465 
1150 630 475-
2909 
15 18 -30 -
35 
Placebo 965 533 371-
1936N 
918 515 350-
1861N 
-6 11 -38 - 
10 
Control 1043 646 212-
2672 
972 503 234-
2128 
-1 17 -31 - 
29 
SD=Standard Deviation 
 
Table 8. Mean differences of group comparisons. 
 
Group Mean Difference Significance (p-value) 
Astym® - Placebo 21% 0.001 
Astym® - Control  16% 0.014 
Control - Placebo 5% 0.675 
 
  
 62 
  63 
Chapter 5 
 
 
Discussion 
 
 
5.1  Introduction 
 The purpose of this study was to determine if Astym® treatment administered 
to the lower extremity would result in an acute change of maximal force output during a 
unilateral isometric squat test among subjects presenting with weakness associated with a 
musculoskeletal injury to the lower extremity.  The group of subjects that received 
Astym® treatment was hypothesized to produce a significantly greater percent change in 
pre-treatment to post-treatment maximal force output than the subjects that received no 
treatment (control) and the subjects that received a sham Astym® treatment (placebo).  
The control and placebo treatment groups were hypothesized not to be statistically 
different in the percent change of maximal force output produced during a unilateral 
isometric squat test.  The results of the current study supported both hypotheses.  Subjects 
that received Astym® treatment increased maximal force output of the lower extremity 
immediately following treatment by an average of 15% from pre-treatment values. The 
percent change in maximal force output (Newtons) was significantly greater for the 
subjects that received Astym® treatment compared to the placebo (p=0.001) and control 
(p=0.01) treatment groups.  The placebo treatment and a control treatment were found not 
to be statistically different (p=0.68) and averaged a negative change of maximal force 
output by 6% and 1%, respectively.    
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 This discussion will provide additional analysis on the results of the current 
study.  Specifically, the discussion will explore the potential mechanisms that may 
explain the observed increase of maximal force output following Astym® treatment and 
compare the effect of Astym® treatment on muscular strength to other interventions 
including joint mobilization, vibration, massage, and other forms of instrumented soft-
tissue mobilization that may share similar mechanisms to affect muscle performance. The 
clinical significance of the results of the study will be discussed as well as consideration 
for the limitations of the study that may affect the interpretation of the results of the 
current study.  The discussion will conclude with suggestions for possible future 
investigations stemming from the results of the current study.  
   
5.2  Percent Change in Maximal Force Output  
 The main finding from the current study was that subjects that received Astym® 
treatment improved maximal force output (Newtons) of the lower extremity by an 
average of 15% immediately following treatment. This was significantly greater (p<0.01) 
than the average 1% and 6% decrease in maximal force output (Newtons) demonstrated 
in the control and placebo treatment groups, respectively. The effect size calculated for 
the analysis of variance that compared the treatment groups was η2 = 0.27.  The effect 
size describes the magnitude of the differences between the groups.145 According to 
Cohen,145 a partial eta-squared calculated for an analysis of variance that is greater than 
0.14 is considered to be a “large” effect size.  A partial eta-squared also describes the 
proportion of variance in the dependent variable explained by the independent variable.  
The calculated eta-squared (η2 = 0.27) suggests that the type of treatment received by the 
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subjects in the current study explains 27% of the variance in the percent change in 
maximal force output.  Although this is considered a large effect size,145 greater than 70% 
of the variance in the maximal force output is explained by factors other than the type of 
treatment received by the subjects.     
 An analysis of the individual performances of the subjects may help to identify 
other potential factors that may explain the variance in the percent change of maximal 
force output.  Figure 8 is a plot graph showing the percent change in maximal force 
output of each of the subjects according to the respective treatment groups.  Eleven out of 
the 15 subjects that received Astym® treatment had an improvement of maximal force 
production greater than the minimal detectable change of 7.5% established for the 
isometric squat test during pilot testing (Appendix B).The minimal detectable change 
represents an estimate of the smallest amount of change that is not due to measurement 
error and may be used to determine if the individual performances were likely due to 
measurement error or a true change in maximal force output.146  Conversely, only 4 
subjects that received the control treatment and 1 subject that received the placebo 
treatment exhibited a positive percent change in maximal force output greater than the 
minimal detectable change.  
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Figure 8.  Plot Graph of Percent Change of Maximal Force Output by Treatment Group 
 
         Astym     Placebo     Control             Minimal Detectable Change 
 
 The plot graph of individual performances shows a wide dispersion of values 
within the Astym® treatment group.  This explains the rather large standard deviation of 
the percent change in maximal force output that was computed for subjects in the Astym® 
treatment group.  The type and location of diagnosis may help to explain variance in the 
percent change of maximal force output found in the group of subjects that received 
Astym® treatment.   
 
5.2.1 The Influence of the Location of the Diagnosis 
 Of the four subjects in the Astym® treatment group that did not improve beyond 
the minimal detectable change, two subjects had diagnoses involving the foot and ankle 
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region.  A closer look at the results of the Astym® treatment group revealed that subjects 
that were diagnosed with a condition affecting the proximal aspect of the lower extremity 
(hip, thigh, and knee regions) tended to have a greater percent change in maximal force 
output compared to the subjects with diagnoses affecting the distal portion of the lower 
extremity (leg, ankle, and foot).  Table 9 presents the average percent change in maximal 
force output according to the location of the subject’s musculoskeletal diagnosis. This 
observation could be related to the specific demands of the isometric squat test. Muscles 
of the hip, thigh, and knee regions have shown greater muscle activation during a squat 
compared to muscles of the leg, ankle and foot regions.147 Thus the isometric squat test 
may be more likely to have a positive change in maximal force production for individuals 
with a diagnosis affecting the proximal portion of the lower extremity. The current study 
was not powered to perform a statistical comparison that would reveal whether the 
percent change of maximal force output was indeed influenced by the location of the 
individual’s diagnosis, but may provide the groundwork for a future study that 
investigates the influence on the location of diagnosis on changes in muscle performance 
following Astym® treatment. 
 
5.2.2 The Influence of the Type of Diagnosis 
 The type of diagnoses may have also contributed to the variance in the percent 
change of maximal force output within the Astym® treatment group.  The subjects that 
participated in the study all had diagnoses affecting the musculoskeletal system.  These 
diagnoses were further categorized by involvement of contractile (musculotendinous) and 
non-contractile structures.  Table 9 shows the mean percent change of maximal force 
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output according to diagnoses involving musculotendinous versus non-contractile 
structures.  The subjects in the Astym® treatment group that were diagnosed with a 
musculotendinous condition had an average percent change in maximal force output of 
21% versus 13% for those with a diagnosis involving non-contractile structures.  Again, 
an accurate statistical comparison cannot be made with the small sample size from the 
current study.  The findings do, however, illustrate the need to perform a future 
investigation to determine the effects of diagnosis type on muscle performance following 
Astym® treatments.  
 
Table 9.  Percent Change in Maximum Force Output following Astym® Treatment by 
Diagnosis Region and Type.   
Diagnosis Categories 
Region     Type 
Hip-Thigh-Knee 
Regions 
Leg-Ankle-Foot 
Regions 
Musculotendinous Non-Contractile 
Hip 15%(n=2) Leg NA(n=0)  
 
 
21%(n=5) 
 
 
 
13% (n=10) 
Thigh 28%(n=2) Ankle 17%(n=3) 
Knee 20%(n=6) Foot -11%(n=2) 
TOTAL 20%(n=10) TOTAL   5%(n=5) 
 
 
5.3  Proposed Mechanisms Contributing to Increased Muscular 
Performance Following Astym® Treatment 
 The mechanisms through which Astym® treatment enhances muscular 
performance are unknown, but previous reports in the literature regarding other methods 
of soft-tissue mobilization would suggest that Astym treatment may influence muscle 
performance through modulation of pain, an increase of blood flow, neuromuscular 
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facilitation, or mechanical sensitivity of calcium channels within the muscle 
tissue.35,70,87,148   This section will explore possible physiological explanations as to why 
subjects that received Astym® treatment demonstrated an acute improvement of muscular 
strength. 
 
 
5.3.1  Modulation of Pain  
 Pain can be a powerful inhibitor of muscle strength. 66-68  In individuals 
experiencing weakness accompanied by pain, a reduction of pain will often lead to a 
subsequent improvement of muscle performance.69  Therefore Astym® treatment may be 
capable of  influencing muscular strength by modulating the perceived pain of the 
subject.  Soft-tissue mobilization techniques such as Astym® treatment are theorized to 
mediate pain through the gate-control and/or descending pain suppression mechanisms. 70 
Under the principle of the gait-control theory of pain, Astym® treatment provides a 
mechanical stimulation of the larger peripheral nerve fibers found in the soft-tissue that 
block the painful stimuli transmitted by smaller nerve endings called nocioceptors.70   
Astym® treatment may also trigger descending pain suppression mechanisms that cause 
the release of endogenous opiates at the spinal level receiving the painful input.70 These 
endogenous opiates, known as endorphins, work to blunt the transmission of painful 
stimuli to the brain.  Soft-tissue mobilization techniques have been previously shown to 
cause an increase of serum endorphins for up to one hour following treatment.76 It is 
possible that Astym® treatment could cause a release of endorphins to reduce pain that 
would result in improved muscle performance.56  
 In the current study, pain was assessed using the numeric pain score during pre-
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treatment and post-treatment isometric squat tests. The Astym® treatment group did not 
show an improvement of pre-treatment (2/10) to post-treatment (2/10) pain scores. The 
placebo group averaged a 2/10 pre-treatment pain score and a 3/10 post-treatment pain 
score while the control group averaged a pre-treatment pain score of 3/10 and a post-
treatment pain score of 3/10. Thus, the average pain scores show that the improvement of 
maximal force output in the Astym® treatment group was not accompanied by a reduction 
of pain reported during the unilateral isometric squat tests.  Further, a majority of the 
subjects in the Astym® treatment group (7/11) that demonstrated an improvement in 
maximal force output did not show an improvement in their post-treatment pain scores.  
The improvements of muscular strength for these subjects cannot be explained simply by 
a reduction of pain reported during the unilateral isometric squat tests.  The average pain 
scores of the subjects in the Astym® treatment group do not suggest that pain modulation 
played a significant role in an improvement of maximal force output.  
5.3.2  Increase of Blood Flow 
 Another possible explanation for the observed effect of Astym® treatment on 
acute muscle strength may be explained by an increase of blood flow to the treated 
musculature.  The subjects that received the Astym® treatment were noted to have a 
hyperemic response to the treated areas. This was evident by a red/flushed appearance of 
the color of the skin and an increase of the tissue temperature to the touch. The subjects 
that received the placebo and control treatments did not exhibit a hyperemic response.  
Perhaps these observations suggest that an increase of blood flow to the soft-tissues 
occurred in response to the Astym® treatment.  Researchers have shown that soft-tissue 
mobilization techniques can cause an increase of local blood flow blood to the treated 
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tissues.148  Bell 149 demonstrated that the amount of local blood flow nearly doubled from 
baseline measures up to 40 minutes following soft-tissue mobilization.  More recently, 
Franklin et al.150 showed similar increases of blood flow in response to a massage 
protocol that lasted approximately 90 minutes following treatment.  Similarly, 
Dubrosky93 reported increases of muscular blood flow that lasted for greater than 3 hours 
after soft-tissue mobilization. An increase of local blood flow to muscular tissue causes 
an increase of intra-muscular temperature that may be capable of enhancing force output 
during a maximal contraction.35,39, 100, 98   Although soft-tissue mobilization techniques 
have been shown to improve blood flow and muscle tissue temperature, the collective 
research on the immediate effect of soft-tissue mobilization on muscle strength has been 
equivocal.78,79,81,123,124 This decreases the likelihood that an increase of blood flow to the 
treated muscle tissue was the primary cause of the improved maximal force output that 
was observed following Astym® treatment.  However, the effect of Astym® treatment on 
local blood flow could be an interesting topic of further research. 
5.3.3  Neuromuscular Facilitation 
 The observed increase in muscular strength following Astym® treatment could 
also be explained by neuromuscular facilitation.  Neuromuscular facilitation refers to an 
increase of muscle activation through stimulation of the sensorimotor system.27,28 Astym® 
treatment may provide a mechanical stimulus that is processed in the motor centers of the 
central nervous system similar to what researchers have previously described for other 
forms of soft-tissue mobilization.35   In response to the heightened sensory input, central 
motor centers send signals to surrounding muscle tissue that result in greater muscle 
activation.130  The effect of soft tissue mobilization techniques, such as Astym® 
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treatment, on muscular performance may depend on several different factors including 
the speed and pressure through which the soft-tissue mobilization technique is 
administered.40,42-45   Based on reports in the literature that describe how rapid vigorous 
stroking facilitates muscle contraction,30,40,41 the strokes applied with the Astym® 
instruments could likewise have a facilitating influence on muscle contraction. However, 
the influence of sensorimotor stimulation on muscular performance is complex 40,42-45 and 
would require additional study to determine the exact mechanisms through which 
Astym® treatment affects the sensorimotor system to improve muscle performance.   
  
5.3.4 Mechanical Sensitivity of Calcium Channels in Muscle Tissue  
 The mechanical stimulation produced during an Astym® treatment may also work 
directly on the muscle tissue.  Muscle tissue contains mechanically sensitive calcium 
channels. 87 These calcium channels regulate the amount of calcium entering the muscle 
tissue and are sensitive to mechanical stimulation.  The amount of calcium available to a 
working muscle can determine the amount of force it is capable of producing.88-90  This 
phenomenon is known as the Force-Calcium relationship.88-90  Because the amount of 
calcium available to working muscles can be manipulated by mechanically sensitive 
calcium channels, 87 improvements in muscular strength following Astym® treatment may 
be the result of an increase of calcium to the working muscle tissue.  
 
5.4  Comparison to Other Therapeutic Interventions 
 At this point in time there are no reports in the literature that address the 
mechanisms through which Astym® treatment affects muscle performance.  However, 
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research has been performed on therapeutic interventions such as joint mobilization, 
vibration, massage, and other forms of instrument assisted soft-tissue mobilization 
techniques that may share similar proposed mechanisms to influence muscle 
performance.  This section will compare and contrast the findings of the current study to 
previously published literature that has investigated the effects of joint mobilization, 
vibration, massage, and other forms of instrument assisted soft-tissue mobilization 
techniques on acute muscular strength. 
5.4.1  Joint Mobilization 
The subjects from the current study that were randomized into the Astym® 
treatment group demonstrated an average increase in maximal force output of 15%. This 
increase of muscular strength is comparable to the increases in muscular strength that 
have been reported immediately following joint mobilization of the lower extremity.  
Yerys et al.151 studied the effects of hip joint mobilization on muscular strength of the 
gluteus maximus muscle. Subjects that received grade IV mobilization of the hip joint in 
a posterior-to-anterior direction experienced a 14% increase of maximal force output. 
Makofsky et al.152 reported that in subjects that received grade IV hip joint mobilization 
in an inferior direction had an immediate increase of hip abduction force output of 
17.35%.   Ghanbari et al.153 demonstrated an acute increase of maximal voluntary 
isometric contraction of the knee extensors by 18.7% following grade IV posterior-to-
anterior mobilization of the knee joint.  The improvement of strength increased to 23.6% 
at 30 minutes after the treatment.153 
Researchers have proposed that the changes observed in muscle performance 
following joint mobilization occur in response to stimulation of mechanoreceptors found 
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within the joint capsule and surrounding soft tissue structures.151  We may speculate that 
Astym® treatment could also influence muscle performance through stimulation of 
mechanoreceptors found in soft-tissue structures that are directly or indirectly contacted 
by the Astym® instruments.   Both joint mobilization151-153 and Astym® treatment have 
shown to have a positive influence on maximal force output and may work through 
similar physiologic mechanisms to facilitate muscle performance. Additional study is 
needed to determine how manual therapy interventions including joint mobilization and 
Astym® treatment affect the sensorimotor system to influence muscle performance.  
 
 
5.4.2 Vibration   
 
 Vibration is another therapeutic intervention believed to stimulate 
mechanoreceptors in an effort to improve muscle performance.47-53 The acute effects of 
vibration on muscle performance of the lower extremity have been well documented.  
Rhea et al.154 studied the acute effects of whole-body vibration on peak power output 
during a squat test.  Subjects that received a 2 minute whole-body vibration treatment 
prior to squat testing significantly (p<0.05) increased their peak power by 5.20% 
compared to a control group that rested for 3 minutes.154  Jacobs et al.155 demonstrated 
average isokinetic torque generated by the knee extensors improved by 9.6% following a 
6-minute treatment of whole-body vibration immediately prior to isokinetic testing.  A 
similar improvement of 7.8% was noted for the average isokinetic torque of the knee 
flexor muslces.145  McBride et al.156 demonstrated that the inclusion of whole-body 
vibration immediately prior to isometric testing of the gastrocnemius muscle resulted in a 
9.4% increase in maximal isometric force compared to a control group (p<0.05).156 
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Researchers have suggested that vibration stimulates mechanoreceptors found in the 
muscle, tendon, deep fascia, and joint capsule structures,46,157 in a manner similar to that 
described for joint mobilization. The mechanoreceptors respond to the vibration stimulus 
and send signals to the central nervous system that may reflexively increase the firing of 
alpha motor neurons that are traveling back to the working muscle.46,157  This may 
explain the observed increases of muscle activation and performance 46,53,157   
 Some researchers, however, have suggested that the improvements in muscle 
performance in response to vibration are not caused by neuromuscular facilitation, but are 
more likely explained by an increase of intra-cellular concentrations of calcium within 
the muscle tissue.158,159   Cochrane et al.160 proposed that whole body vibration causes 
post-activation potentiation, a phenomenon in which the contractile elements of muscle 
tissue increase their sensitivity to intracellular calcium, thus enhancing the force 
production of the contracting muscle.   Cochrane et al.160 attempted to determine whether 
the increases of muscular strength following whole body vibration were the result of 
neural mediated effects or post-activation potentiation.  The peak force generated by a 
muscle-tendon reflex was used to assess the neural-mediated effects.  The peak force 
generated from a consistent electrical stimulus to the muscle assessed the effects of post-
activation potentiation.  The results showed that peak force from the electrical stimulus 
increased the force production by 12.4%, while force generated from the reflex-induced 
contraction changed only 0.1% and was not statistically significant.  Based on these 
results, the authors concluded that the changes noted following whole body vibration 
were likely related to post-activation potentiation that increased the availability of 
calcium to the contractile elements of muscle tissue.160    As previously described, 
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calcium channels that potentiate muscle contraction have shown to be sensitive to 
mechanical stimulation.87 The work of Cochrane et al.160 supports the theory that the 
improvements in muscular strength following Astym® treatment could be caused by an 
influx of calcium through mechanically sensitive calcium channels within muscle tissue.     
 
5.4.3  Massage 
 The results of the current research project conflict with previous research 
documenting the effects of massage on muscle performance.  Arroyo-Morales et al.77 
used a cross-over design to compare the peak isokinetic torque produced by the 
quadriceps and hamstring muscles following massage versus a sham ultrasound 
treatment.  The peak isokinetic torque of the quadriceps and hamstring following a 
massage protocol of effleurage, petrissage, and tapotement to the gastrocnemius, 
quadriceps, and hamstrings muscles were not greater than the peak torque recorded 
following a sham ultrasound treatment.77  In fact, isokinetic torque of the knee extensors 
was 9-11% less at speeds of 240°/second and 180°/second peak following massage 
compared to a sham ultrasound treatment.77  Wiktorsson-Moller et al.82 reported similar 
findings.  Isokinetic testing at speeds of 30°/second and 180°/second for the quadriceps 
and hamstring muscle groups resulted in statistically significant decreases (equivalent to 
3-10% deficits) in peak isokinetic torque following massage treatment.  Wiktorsson-
Moller et al.82 also tested the quadriceps and hamstring muscle groups isometrically and 
found similar decreases in muscular strength.  McKechnie et al.80 studied the effects of 
massage on isokinetic testing of the plantarflexor muscle group following massage 
treatment.  The results showed that the peak torque of the plantarflexor muscle group did 
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not significantly change and was equivocal to that of a placebo treatment that received 3 
minutes of static light touch to the skin overlying the gastrocnemius muscle.80   
 The difference between the effects of Astym® treatment and massage on muscle 
strength may best be explained by the differences between the techniques.  Astym® 
treatment is performed with the intent to stimulate muscle tissue.12  This requires 
sufficient pressure to allow the instrument to contact the underlying muscle tissue  
indirectly through the skin and superficial layer of fascia.12  Strokes applied with the 
Astym®  instruments are performed rapidly and with enough pressure to appreciate the 
distinct texture that occurs as the instruments indirectly contact muscle tissue.12  The 
massage techniques used in the research studies that investigated the acute effects of 
massage on muscle strength used combinations of effleurage and petrissage techniques 
that were described as slow and rhythmic.77,80,82  Effleurage is a light or gentle massage 
applied over the skin.119,121   With effleurage there is no intent to indirectly contact the 
deep soft-tissue structures, including the muscle tissue.119,121  This is similar to the intent 
described for the placebo treatment of the current research project.  Instead of the 
caregiver’s hands, the placebo treatment was applied with the rounded, non-treatment 
edge of the Astym® instrument.  The Astym® instruments were glided lightly over the 
skin without indirectly contacting the deeper soft-tissue structures including muscle 
tissue.  The subjects in the placebo treatment group did not demonstrate a significant 
difference from the control group(p=.30), and averaged a 6% decrease of maximal force 
output.  The 6% decrease of muscular strength is consistent with subjects that received 
massage treatment in the previously described studies.77,80,82  
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 However, the massage techniques described in the studies above also included 
petrissage techniques.77,80,82   Petrissage is a more aggressive type of massage that may 
indirectly contact muscular tissue with kneading, wringing, or scooping type strokes that 
are believed to facilitate muscle function.119,121   Because effleurage and petrissage were 
often combined in the massage protocols used to investigate the effects of massage on 
muscular strength,77,80,82 it is unknown if the effects of petrissage facilitated or inhibited 
muscular strength.  McKechnie et al 80 suggested that petrissage techniques are a means 
to stretch muscle fibers.  Stretching of muscle fibers is well documented to cause an acute 
decline in muscular performance,132-136,147 and may explain why massage can negatively 
influence muscle performance. Because the instruments are moved rapidly across the 
length of the muscles, there is likely no sustained lengthening of the muscle fibers during 
an Astym® treatment.  As a result, a decline in muscular strength similar to that found 
following stretching or massage may not be expected after an Astym® treatment.  
 
5.4.4  Instrument Assisted Soft-Tissue Mobilization 
 The results of the current study are also different from what has been previously 
reported for forms of instrument assisted soft-tissue mobilization techniques.  Mikesky et 
al.103 studied the effect of the use of a device known as “the Stick” on isokinetic peak 
torque of the knee extensors.  Subjects were tested immediately following each of the 
three treatment conditions:  1)  a 2 minute self-massage of the quadriceps using the 
“Stick” instrument, 2)  a control intervention that received no treatment, and 3) a placebo 
treatment that was described as a sham electrical stimulation treatment.  The peak torque 
generated by the quadriceps muscles following the “Stick” protocol (689.8 N) was not 
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statistically different than the peak torque following the control intervention (687.5 N) or 
following the placebo treatment (681.7 N).103  Sullivan et al.117 studied the use of a foam 
roller-massager device that was administered to the hamstring muscles for 5-10 seconds 
at a constant rate and pressure.  The maximal force produced by the hamstring muscles 
decreased up to 6% following the massage-roller treatment.117   Healey et al.118 used a 
cross-over study design to investigate the effects of self-administered soft-tissue 
mobilization using a foam roller compared to a control treatment that consisted of 
isometric trunk exercises on measures of athletic performance.  The subjects completed 
two separate days of testing that included maximal force output during a squat 
immediately following the designated treatment.  The maximal force output produced 
following the foam roller treatment to muscles of the trunk and lower extremity was not 
different from the control treatment of isometric trunk exercises.  The authors concluded 
that the foam roller intervention to the trunk and lower extremity had no effect on 
maximal force output immediately following the self-administered foam roller 
treatment.118  
 The findings reported by Mikesky et al.103, Sullivan et al.117, and Healey et al.118 
are in contrast to the results of the current study that demonstrated a 15% increase in 
maximal force output following Astym® treatment.  The differences in how Astym® 
treatment is administered versus the other forms of instrument assisted soft-tissue 
mobilization may help to explain the differences in the results.  One of the major 
differences was the length of time in which the treatment was administered.  Mikesky et 
al.103 described a 2 minute treatment time and Sullivan et al.117 described the treatment 
intervention as a 5-10 second treatment over the muscle tissue.  These two studies also 
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isolated the treatment to include only the muscle group that was being tested for muscular 
strength. Healey et al.118 described the treatment administered with the foam roller to be 
30 seconds for each muscle group treated.  The protocol included treatment to the 
quadriceps muscle group, latissimus dorsi, hamstring muscle group, gastrocnemius, and 
rhomboid muscles.   Based on the description of the methods, one may conclude that the 
total treatment time was approximately 2.5 minutes to complete a unilateral treatment.  
Comparatively, the Astym® treatment protocol used in this study averaged 12 minutes to 
complete the subject’s anterior and posterior aspects of the involved extremity.  The 
difference in the total time of treatment and the number of structures treated during the 
session may help to explain the discrepant findings. 
   
5.4.5  Summary of the Comparison of Astym® Treatment to other 
Therapeutic Techniques 
 In the preceding discussion evidence was presented that supports the possibility 
that Astym® treatment enhances muscle performance through neuromuscular facilitation, 
an increase of calcium concentration within the muscle tissue, an increase of blood flow, 
or modulation of pain.  Therapeutic interventions including joint mobilization151-153 and 
vibration154-156 are believed to facilitate the neuromuscular system and have shown 
similar increases of maximal force output to the subjects that received Astym® treatment. 
Vibration has also been shown to open mechanically sensitive calcium channels within 
the muscle tissue, allowing an influx of calcium to enter the muscle tissue and improve 
the ability of the muscle to produce force.88-90 Astym® treatment could have increased 
calcium concentrations within muscle tissue through stimulation of these mechanically 
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sensitive calcium channels to enhance muscle performance. The subjects that received 
Astym® treatment experienced a hyperemic response to the Astym® treatment.  An 
increase of blood flow and tissue temperature associated with a hyperemic response could 
have contributed to an improvement of muscle performance,97,98,100 but no study to date 
has been performed to determine if Astym® treatment results in an increase of blood flow 
and tissue temperature.  Pain modulation was another proposed mechanism believed to 
influence maximal force output following Astym® treatment. However, a majority (7/12) 
of the subjects that improved muscular strength following Astym® treatment did not show 
improvement of self-rated pain scores.  Therefore, pain modulation cannot be considered 
a likely explanation for the results of the current study. 
 The results of the current study are in contrast to the findings that have been 
previously reported on the acute effects of soft-tissue mobilization on muscle 
performance.77,80,82  There are inherent differences in the way that Astym®  treatment is 
administered that include the speed, the pressure, and the length of treatment when 
compared to other instrument 103,117,118 and non-instrument assisted soft-tissue 
mobilization techniques 77,80,82 that have shown to have a negative impact on muscle 
performance.  Instrument assisted techniques that more closely resemble the Astym® 
treatment protocol for the lower extremity have not been studied to determine the effect 
on muscular performance.  Additional research is needed to determine how instrument-
assisted soft-tissue techniques like Astym® treatment can be used to enhance muscle 
performance.   
 
 
 82 
5.5  Clinical Significance 
 The results of the current study may have a clinical significance to physical 
therapists treating patients with deficits in muscular strength due to a musculoskeletal 
condition.  To put a clinical perspective on the magnitude of the change that Astym® 
treatment may have on muscular strength we can use the following clinical example.  A 
patient with a musculoskeletal injury to the lower extremity may produce 1000 Newtons 
of force during a maximal isometric squat test compared to 1200 Newtons on their non-
involved side.  The maximal force produced during the squat test on the involved side 
equates to squatting a maximum of 225 pounds.  Following an Astym® treatment to the 
lower extremity, we would expect the average maximal force output to increase by 15%.  
For our clinical example, we would expect the patient to have an immediate improvement 
of their maximal squat from 225 pounds to nearly 260 pounds or for an improvement of 
35 pounds.  This change in force output could temporarily enhance their ability to 
perform their strengthening program, however, it remains unknown how long the effect 
will last.  
  Multi-joint, lower extremity muscular strength has been shown to be directly 
related to the functional abilities of an individual.21  Muscular strength measured with a 
unilateral squat test has been associated with ambulatory and stair climbing function.22  
Lower extremity muscular weakness is also a risk factor for falls in an elderly 
population.23  In a younger, athletic population, lower extremity strength has been related 
to sprinting speed  as well as measures of agility and jumping ability.24,25,161  The 
consensus of current scientific literature would suggest that multi-joint lower extremity 
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strength has implications to a wide range of functional activities, from basic ambulatory 
function to advanced athletic performance.  
 An area of future research would be to assess if the acute change in muscular 
strength following Astym® treatment in fact enables patients to perform functional tasks 
with less difficulty.  This could include activities of daily living such as transitioning 
from a seated to a standing position or climbing stairs.  Astym® treatment may also be 
used to help athletes with musculoskeletal injuries quickly improve their abilities to run, 
change direction, or jump.  Maximizing the effectiveness and efficiency of treatment 
sessions in a physical therapy practice may be of elevated importance in today’s health 
care environment where a physical therapist may be challenged to manage a patient’s 
deficits in a limited number of visits.  The results of the current study support the use of 
Astym® treatment in the management of patients with a documented weakness from a 
musculoskeletal injury/condition.  The improvement in muscular strength produced by an 
Astym® treatment may be seen best in individuals who have a diagnosis in which the 
musculotendinous structures of the knee thigh region are injured.  Based on the results of 
the current study, conditions affecting non-contractile tissues or those involving the 
structures of the foot, ankle, or leg may be less likely to experience an immediate 
increase in muscle strength measured with a unilateral squat test.  Therapists may choose 
to use Astym® treatment as an efficient means to improve muscular strength, especially 
among patients with lower extremity weakness caused by a musculotendinous injury to 
the knee or thigh region. 
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 5.6  Limitations 
 There are limitations to the current study that deserve consideration when 
interpreting the results.  Limitations that challenge the cause and effect relationship 
established between the independent variable (Astym® treatment) and the dependent 
variable (percent change of maximal force output) are referred to as threats to the internal 
validity of the study. This section will explore the limitations of the study that pose 
potential threats to internal validity and how the threats were controlled.  It will also 
explore the potential threats to external validity.  External validity refers to how the 
results of the study can be generalized in other populations.  The characteristics of the 
subjects enrolled in the current study will be analyzed to determine the generalizability of 
the reported effects of Astym® treatment on muscular strength. 
5.6.1  Threats to Internal Validity 
 There are several potential threats to the internal validity of this study:  selection 
bias, testing effects, statistical regression, experimental mortality, instrumentation, and 
design contamination.  Each of these threats can affect the ability to establish a cause and 
effect relationship between Astym® treatment and maximal force output.  
5.6.1.1  Selection Bias 
 The most substantial threat to internal validity in a multi-group study design that 
was employed in the current study is selection bias.162  A selection bias occurs when the 
characteristics of the subjects in the groups that are being compared are inherently 
different from each other.162  Thus the causality of the observed outcome cannot be 
delineated from the inherent differences between the groups or the effect of the 
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independent variable on the dependent variable.  Random assignment of subjects to the 
treatment groups was performed to minimize the likelihood of a selection bias.  Statistical 
comparisons of the treatment groups showed that none of the groups were statistically 
different with regard to age, height, weight, lower extremity functional score, lower-
extremity dominance, involved versus uninvolved strength deficit, or diagnosis.  
Therefore, it was concluded that these subject characteristics likely did not contribute to 
the main outcome of the study.  The distribution of gender was not statistically different.  
However, the Astym® treatment group had a greater female to male ratio (5:1), in 
comparison to the control (3:1) and the placebo group (3:2).  Although the males in the 
Astym® treatment group proved to have a greater percent change in maximal force output 
(20%) compared to the females (13%), the unequal distribution of males to females does 
not allow an accurate statistical comparison to rule out the possibility of a gender bias 
that could have influenced the results of the study.  
5.6.1.2 Testing Effects 
 Testing effects are another consideration in a pre-test/post-test type of study design 
that was used for this research project.  Testing effects occur when the pre-test influences 
the results of the post-test.162 Cumulative fatigue and learning effects due to the 
familiarity of the testing procedures using the computerized leg press are two possible 
testing effects to consider when interpreting the results of the current study. Pilot testing 
that investigated the learning/fatigue effect during repeated testing on the computerized 
leg press machine (Appendix C) was done prior to the initiation of the current study. 
Based on this pilot data a familiarization protocol138 was adopted to control for 
learning/fatigue effects for the computerized leg press machine.  
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 The data from the control group as well as the data collected on the non-involved 
side of the subjects enrolled in the study can be analyzed to assess the influence of testing 
effects. The subjects that received the control condition had a -1 percent change of 
maximal force output. Analysis of pre-test to post-test measures of the non-involved side 
averaged a 4-6% decrease in percent change of maximal force output for each of the 
designated treatment groups.  The results of the pilot study as well as the analysis of data 
collected for the control group and the non-involved sides of all the subjects demonstrates 
strong evidence that testing effects did not impact the results of the current study.  Thus 
testing effects were not likely explanations for the improvement noted in maximal force 
output of the subjects that received Astym® treatment.   
 
5.6.1.3  Instrumentation Effects 
 Poor consistency and reliability of the instruments used to collect data is another 
possible threat to internal validity.162  The computerized leg press machine used for this 
study was calibrated to within 0.1 Newtons.  Pilot data was collected prior to the 
initiation of the current study to establish test-retest reliability and criterion validity of the 
computerized leg press machine. (Appendix A and B).  The computerized leg press 
machine demonstrated excellent criterion validity (r=0.99) to a digital force 
dynamometer.  The test-retest reliability of the leg press machine was also excellent with 
an ICC(2,1) of 0.99.  Based on the pilot data, it is unlikely that an instrument effect 
occurred to influence the results of the study.   
 An instrument effect may have also occurred as the investigator performed 
treatment with the Astym® instruments.  While the Astym® treatment protocol was 
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standardized with regard to the order and the areas treated, the amount of pressure 
applied during the treatment differed according to the thickness of the superficial fascia 
overlying the muscular tissue.  A lack of standardized treatment pressure may be 
perceived as a weakness or confounding variable in the study. Using a predetermined 
pressure, however, would presumably create a bias where leaner subjects would likely 
receive greater mechanical stimulation of the soft-tissue compared to subjects with 
greater mass or thicker adipose tissue over the muscle tissue.  To account for the 
variability of body composition among the subjects, the amount of pressure applied 
during treatment was dependent on the appreciable change of tissue texture noted by the 
investigator during the Astym® treatment.  This allowed a consistent Astym® treatment 
experience for each individual subject and is consistent with how Astym® treatment is 
performed in clinical settings.  
 
5.6.1.4 Regression to the Mean 
 A regression to the mean may occur when the subjects score extremely high or 
extremely low on the measurement of interest.  To be included in the current study, 
subjects had to demonstrate a minimal deficit of 10% of maximal force output of their 
involved side compared to the uninvolved side.  Since subjects demonstrated a strength 
deficit to qualify for the study, there could be concern that their scores would improve 
regardless of treatment intervention with repeated testing. The average percent deficits of 
the involved side to the non-involved side were 22%, 19%, and 20% for the Astym®, 
placebo, and control treatment groups, respectively.  The groups were not statistically 
different for the average percent strength deficits, yet only the Astym® treatment group 
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showed a positive improvement of maximal force output following treatment.  Given that 
the control and placebo groups did not improve maximal force output lessens the 
likelihood that a regression towards the mean would explain the improvement observed 
in the Astym® treatment group.  
   
5.6.1.5 Design Contamination 
 Design contamination occurs when the subjects become aware of his/her 
treatment group.  This may motivate the subjects to apply more effort to meet the 
expectations of the researchers. In the current study, subjects were blinded to their 
assigned group.  Only the primary investigator knew the treatment that was administered 
to each subject.  A second investigator performed all the testing and was blinded to the 
treatment received by each subject.  Blinding of the subject and the investigator 
performing the testing can help to reduce the effects of design contamination.  The 
blinding methods used in the current study therefore minimize the threat of design 
contamination. 
  
5.6.1.6  History and Maturation Effects 
 An effect of history can occur when an event in the subject’s past influences their 
outcome during the study.  Similarly, maturation effects occur as the natural process of 
growth and aging.  History and maturation are potential threats that are more commonly 
associated with longitudinal studies.  The purpose of the current study was to examine the 
acute effects of Astym® treatment on muscle strength, and thus the contracted time 
between pre-test and post-test measures limits the effects of history or maturation on the 
  89 
results of the current study.  However, if a subject had previously been exposed to 
Astym® treatment, this could alter his/her perceptions of the treatment and lead to a 
different result.  For this reason, subjects with previous exposure to Astym® treatment 
were excluded from participation in the study.   
 
5.6.2  Threats to External Validity 
 External validity refers to the extent to which the results of the study are 
generalizable to other populations.  There are threats to the external validity of this study, 
with regard to the type of the diagnoses as well as pre-existing weakness that may limit 
the generalizability of the results of the current study.  This section will explore the how 
the type of diagnosis and pre-existing weakness may affect the generalizability of the 
results to other populations of subjects.   
 The conclusions from this study should only be applied to adult patients with 
muscular weakness caused by a musculoskeletal injury or condition affecting the lower 
extremity.  The sample of subjects from the current research study was recruited from an 
outpatient physical therapy facility believed to be representative of a population 
commonly seen in other outpatient physical therapy facilities.  The diagnoses of the 
subjects that participated in this research study were all musculoskeletal in nature. There 
are other conditions that may cause muscular weakness including neuromuscular disease 
or conditions that impair the central or peripheral nervous systems. None of the patients 
in the study presented with weakness caused by a neuromuscular condition or disease 
affecting the nervous system.  Individuals with the aforementioned conditions may have 
debilitating weakness that would benefit from therapeutic interventions to improve 
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muscular performance.  Although the results of the current study suggest a positive 
influence of Astym® treatment on muscle strength among subjects with musculoskeletal 
conditions, it remains unknown if weakness caused by neuromuscular disease or 
impairments to the nervous system would experience a similar improvement of muscular 
performance.  
 All of the subjects enrolled in the current study presented with a measurable 
strength deficit of at least 10% when compared to the non-involved side.  Those subjects 
that did not have a minimum strength deficit of 10% were excluded.  Therefore it remains 
unknown how Astym® treatment may influence strength in those without a deficit.  
Athletes are a population that may not present with weakness, but may benefit from an 
increase in muscle performance.  Anecdotal reports from athletes note enhanced athletic 
performance immediately following Astym® treatment.  However, no study has been 
performed to test the influence of Astym® treatment on athletic performance.  The results 
of the current study are encouraging that Astym® treatment may facilitate athletic 
performance by improving muscular strength, but the sample from this study included 
only subjects that had muscular weakness and a known injury.  Therefore, the results 
cannot be generalized to an athletic population that is healthy or does not have an existing 
strength deficit.   
5.7  Future Research Considerations 
 The use of Astym® treatment in the management of musculoskeletal pathology is 
relatively new and there remains limited evidence describing its effects on individuals 
with various musculoskeletal conditions.  The results of the current research project have 
demonstrated how Astym® treatment acutely affects maximal force output during an 
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isometric squat test.  This discovery has generated interest in additional inquiries 
examining the effects of Astym® treatment.  
 While Astym® treatment was shown to cause an acute change in muscle strength, 
the longevity of this change remains unknown.   Researchers have reported mechanical 
stimulation in the form of brushing of the skin can cause excitatory changes in muscle 
activity for up to 40 minutes after treatment.40,41  More current research has shown that 
the mechanical stimulation produced with joint mobilization can influence muscular 
strength for 15-30 minutes after treatment.  Ghanbari et al.153 demonstrated that while 
muscular strength of the knee extensors occurred immediately following a grade IV 
mobilization of the knee joint, the maximal increase of muscular strength occurred 30 
minutes after the joint mobilization. Makofsky et al.152 noted significant improvements in 
hip abductor strength measures 15 minutes following grade IV inferior mobilization of 
the hip joint.  Grindstaff et al.163 studied the temporal effect of joint mobilization on 
muscular strength.  The results of the study by Grindstaff et al.163 showed a statistically 
significant improvement in muscular strength and activation of the quadriceps muscle 
group immediately following lumbopelvic manipulation, but the change was not 
sustained upon repeated testing at 20, 40, and 60-minutes after the manipulation. Based 
on these studies, one may speculate that the effect of Astym® treatment on muscular 
strength would last 20-40 minutes, similar to the sustainability that has been previously 
reported for joint mobilization and manipulation.  A study that investigates the effect of 
Astym® treatment on muscle strength over time is needed to determine the sustainability 
of the effects of Astym® treatment on muscular strength.   
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  In addition to muscular strength, other aspects of muscle performance such as 
muscular power may also be influenced by Astym® treatment. Power is defined as the 
amount of energy output per unit of time and is often expressed as the amount of 
muscular force multiplied by the velocity of movement.164  Muscular power is a strong 
predictor of self-reported functional status 165 and predictive for falls in an elderly 
population.166  Muscle power has also been associated with athletic performance in 
cycling, 167 swimming, 168 jumping, 169 and sprinting 170 Current research indicates that 
soft-tissue mobilization techniques such as massage and self-administered instrument-
assisted techniques do not improve muscle power.   McKechnie et al.80 demonstrated no 
significant change in measures of muscle power following petrissage and tapotement 
massage.  Mikesky et al. 103 demonstrated no improvement of measures of muscle 
performance after treatment using “the Stick”.  Similarly, no change in muscle power 
during a vertical jump was observed by Healey et al.118 after self-administered soft-tissue 
mobilization with a foam roller.  These studies, however, also demonstrated no effect on 
muscular strength, which is contradictory to the findings from this current research 
project.  Whether Astym® treatment would cause an increase of muscular power that is 
similar to the increase that was demonstrated for muscular strength is unknown. There is 
a need for studies that examine the effects of Astym® treatment on muscular power and 
the implications to functional activities, athletic performance, and injury prevention.  
 Another potential research inquiry may be to investigate how Astym® treatment 
can directly influence function. The ability to perform activities of daily living such as 
walking and negotiating stairs have been related to measures of muscular strength.118  
Muscular strength has also been related to athletic performance in measures such as 
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timed sprinting speed and vertical jump height.24,25,161   Since the results of the current 
research project demonstrated improvements in strength, it may be hypothesized that 
functional performance measures may also demonstrate acute improvements.  Previous 
research has shown that Astym® treatment can help to improve measures of self-reported 
function.1,4,7,11,17  However, these studies were primarily case series or studies and 
examined the impact of Astym® treatment over the course of several treatments. As a 
result, there remains little quality and quantity of evidence to establish a cause and effect 
relationship between Astym® treatment and measures of functional performance.  Future 
research may investigate the effect of Astym® treatment on functional performance tests 
through clinically controlled trials.  Examples of functional performance tests may 
include the stair climb test, that measures the time it takes a patient to ascend and descend 
a flight of stairs, or the timed-up-and-go test that measures the ability to transition from 
sit-to-stand and walk.171  Functional performance in an athletic population may be 
measured by agility and balance tests, timed run tests, and hop/jump tests.172  Future 
research that examines the impact of Astym® treatment on measures of functional 
performance, specifically on the abilities of individuals to perform common daily or 
athletic activities may help to determine the clinical significance of the acute changes in 
muscular strength observed in the current research project.  
 Future research may also investigate the mechanisms such as pain modulation, 
neuromuscular facilitation, mechanosensitivity of muscle tissue, and increased blood 
flow, through which Astym® treatment is hypothesized to influence muscular strength.  
Previous studies have investigated the effects of therapeutic interventions on acute 
muscle pain and weakness caused by an aggressive eccentric exercise protocol.173-175  
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Eccentric exercise protocols can create delayed onset muscle soreness and cause 
temporary damage to muscle tissue that coincides with a loss of muscular strength.173-175  
A research project that induces delayed onset muscle soreness and then evaluates the 
effect of Astym® treatment to reduce the associated pain and restore muscular strength 
deficits may help to determine the association of pain reduction and muscle performance.  
Such a study may also determine if Astym® treatment is indicated to manage delayed 
onset muscle soreness.  Pain can also be produced in laboratory settings with a hypotonic 
injection into a joint.66,71,73,175-177  Muscle strength measures have been shown to 
significantly decrease following an injection of hypotonic solution into an otherwise 
healthy joint. 66,71,73,175-177 A research project that examines the effect of Astym® treatment 
on muscle strength after laboratory induced joint pain may help to explain if improved 
muscle performance is related to reduction of pain and may further determine the role of 
Astym® treatment for patients with impaired muscular strength caused by joint pain.   
 To determine the effect of Astym® treatment on the sensorimotor system, a 
clinical trial may be constructed that uses an anesthetic nerve block that impedes sensory 
input to the brain, but does not affect motor signals to working muscles.  The current 
study used a placebo intervention that consisted of tactile stimulation using lighter 
pressure to avoid contact with the deeper, musculoskeletal tissue.  The placebo group 
received sensory stimulation from the mechanoreceptors found in the skin but differed 
from the Astym® treatment group in that there was careful attention not to stimulate the 
musculotendinous and fascial structures deep to the skin.  The results showed a 
statistically significant increase of muscular strength for the Astym® treatment group, but 
not the placebo group.  This could suggest that tactile stimulation of the skin does not 
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play a major role in the acute changes in muscular strength that were observed in this 
study, but perhaps stimulation of the mechanoreceptors in the musculotendinous and 
fascial structures are important to inducing a change in muscular strength.  There is 
conflicting evidence regarding the influence of tactile stimulation and muscle 
performance.  Tactile stimulation of the skin while wearing a neoprene sleeve was a 
proposed mechanism explaining improved measures of muscle performance according to 
research performed by Call.178  Similarly, studies have shown that use of elastic 179,180 and 
non-elastic taping techniques 181-183 increases muscle activation and performance.  Other 
studies, however, have shown no influence of taping techniques on muscle 
performance.184-189 A recent meta-analysis of the evidence of elastic taping on muscle 
performance showed inconsistent findings and reached no definitive consensus on the 
effect of various taping techniques on muscle performance.190  Therefore, it remains 
uncertain what effect tactile stimulation to the skin may have on measures of muscle 
performance.  A research project that compares the impact of Astym® treatment on 
muscle strength in conditions with sensory input blocked versus conditions with the 
sensory system in tact may help to further determine if stimulation of the sensorimotor 
system from Astym® treatment could explain the acute changes in muscular strength 
observed in the current research study.     
 Determining how mechanical stimulation influences calcium concentrations in 
muscle tissue may further help to explain the mechanisms through which Astym® 
treatment influences muscular strength.  However, measures of intra-cellular calcium are 
difficult to attain in vivo and require advanced laboratory techniques to measure.191  
Laboratory studies using animal models may compare intra-muscular calcium 
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concentrations of muscle tissue treated with Astym® to muscle tissue not treated with 
Astym®.  Ziman et al.191 described novel methods to measure concentrations of calcium 
released by the sarcoplasmic reticulum, however, these methods have not been used on 
human tissue.  To determine the effect of Astym® treatment on calcium exchange in 
muscle tissue, animal studies using advanced methodology would be necessary until 
novel measures can be developed that can quantify calcium exchange occurring in human 
muscle in vivo. 
 The effect of Astym® treatment on blood flow may be another potential research 
question.  Previous research has demonstrated that soft-tissue mobilization in the form of 
massage increases local blood flow to treated areas. 93,95,149 Massage has also shown to 
increase muscle temperature.99  While it would be reasonable to suggest that Astym® 
treatment may induce similar increases in blood flow and tissue temperature, no study to 
date has been performed to investigate the effect of Astym® treatment on local blood flow 
and tissue temperature. Such studies would provide evidence that would help determine if 
increases of blood flow and tissue temperature accompany improvements in muscular 
strength.  
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5.8  Conclusions 
1.   Astym® treatment caused an acute improvement on maximal force output during a 
unilateral isometric squat test.  Subjects that received Astym® treatment had a 
significantly greater percent change in pre-treatment to post-treatment maximal force 
output than the subjects that received no treatment (control) and the subjects that 
received a sham Astym® treatment (placebo). 
2.   Subjects that received the control and placebo treatment did not yield an acute 
improvement in maximal force output during a unilateral isometric squat test.  
3.   Future research is needed to understand the physiologic mechanisms that explain 
how Astym® treatment increases muscular strength, the longevity of the observed 
increases in muscular strength, and to determine if Astym® treatment will also result 
in acute changes in muscle power, functional abilities, and athletic performance.   
  
 98 
REFERENCES 
 1. McCrea EC, George SZ. Outcomes following augmented soft tissue mobilization for patients 
with knee pain: A case series. Orthopaedic Physical Therapy Practice. 2010;22(2):69-74. 
2. Loghmani MT, Warden SJ. Instrument-assisted cross-fiber massage accelerates knee ligament 
healing. J Orthop Sports Phys Ther. 2009;39(7):506-514. 
3. Fowler S, Wilson JK, Sevier TL. Innovative approach for the treatment of cumulative trauma 
disorders. Work. 2000;15(1):9-14. 
4. Davies CC, Backopp DY. Use of astym treatment on scar tissue following surgical treatment 
for breast cancer: A pilot study. Rehabilitation Oncology. 2010;28(3):3-12. 
5. Haller KH, Helfst RH, Wilson JK, Sevier TL. Treatment of chronic elbow pain. Physical 
Therapy Case Reports. 1999;2(5):195-200. 
6. Henry P, Panwitz B, Wilson JK. Rehabilitation of a post-surgical patella fracture: Case report. 
Physiotherapy. 2000;86(3):139-142. 
7. Henry P, Panwitz B, Wilson JK. Treatment of a bilateral total knee replacement using ASTM. 
Physical Therapy Case Reports. 1999;2(1):27-30. 
8. McCormack JR. The management of mid-portion achilles tendinopathy with astym(R) and 
eccentric exercise: A case report. Int J Sports Phys Ther. 2012;7(6):672-677. 
9. McCormack JR. The management of bilateral high hamstring tendinopathy with ASTYM(R) 
treatment and eccentric exercise: A case report. J Man Manip Ther. 2012;20(3):142-146.  
  99 
10. Melham TJ, Sevier TL, Malnofski MJ, Wilson JK, Helfst RH. Chronic ankle pain and fibrosis 
successfully treated with a new noninvasive augmented soft tissue mobilization technique 
(ASTM): A case report. Med Sci Sports Exerc. 1998;30:801-804. 
11. Slaven EJ, Mathers J. Management of chronic ankle pain using joint mobilization and 
ASTYM(R) treatment: A case report. J Man Manip Ther. 2011;19(2):108-112.  
12. Sevier T, Stover S, Helfst R, Zanas J. ASTYM clinical manual. 2009. 
13. Davidson CJ, Ganion LR, Gehlsen GM, Verhoestra B, Roepke JE, Sevier TL. Rat tendon 
morphologic and functional changes resulting from soft tissue mobilization. Med Sci Sports 
Exerc. 1997;29(3):313-319. 
14. Gehlsen GM, Ganion LR, Helfst R. Fibroblast responses to variation in soft tissue 
mobilization pressure. Med Sci Sports Exerc. 1999;31(4):531-535. 
15. Sevier TL, Helfst RH, Stover SA, Wilson JK. Clinical trends on tendinitis. Work. 
2000;14(2):123-126. 
16. Baker D, Wilson JK. Bilateral carpal tunnel syndrome in a piano teacher. Physical Therapy 
Case Reports. 1999;2(2):73-76. 
17. Wilson JK, Sevier TL, Helfst RH, Honing EW, Thomann A. Comparison of rehabilitation 
methods in the treatment of patellar tendinitis. J Sport Rehabil. 2000;9:304-314. 
18. American Physical Therapy Association. Guide to physical therapist practice.  1999;77. 
19. Sevier TL. ASTYM and the NFL. Published March 19th 2011;[blog]. 
 100 
20. Caldwell LS, Chaffin DB, Dukes-Dobos FN, et al. A proposed standard procedure for static 
muscle strength testing. The American Industrial Hygiene Association Journal. 1974;35(4):201-
206. 
21. Azegami M, Ohira M, Miyoshi K, et al. Effect of single and multi‐ joint lower extremity 
muscle strength on the functional capacity and ADL/IADL status in japanese community‐
dwelling older adults. Nurs Health Sci. 2007;9(3):168-176. 
22. Hamalainen HP, Suni JH, Pasanen ME, Malmberg JJ, Miilunpalo SI. Predictive value of 
health-related fitness tests for self-reported mobility difficulties among high-functioning elderly 
men and women. Aging Clin Exp Res. 2006;18(3):218-226. 
23. Horlings CG, van Engelen BG, Allum JH, Bloem BR. A weak balance: The contribution of 
muscle weakness to postural instability and falls. Nature Clinical Practice Neurology. 
2008;4(9):504-515. 
24. Comfort P, Bullock N, Pearson SJ. A comparison of maximal squat strength and 5-, 10-, and 
20-meter sprint times, in athletes and recreationally trained men. J Strength Cond Res. 
2012;26(4):937-940.  
25. Parchmann CJ, McBride JM. Relationship between functional movement screen and athletic 
performance. J Strength Cond Res. 2011;25(12):3378-3384.  
26. Voss DE, Ionta MK, Myers BJ, Knott M. Proprioceptive neuromuscular facilitation: Patterns 
and techniques. Harper & Row Philadelphia; 1985. 
27. Riemann BL, Lephart SM. The sensorimotor system, part I: The physiologic basis of 
functional joint stability. Journal of athletic training. 2002;37(1):71. 
  101 
28. Purves D, Augustine GJ, Fitzpatrick D, et al. Mechanoreceptors specialized to receive tactile 
information. . 2001. 
29. Proske U, Gandevia SC. The proprioceptive senses: Their roles in signaling body shape, body 
position and movement, and muscle force. Physiol Rev. 2012;92(4):1651-1697. 
30. Schleip R. Fascial plasticity–a new neurobiological explanation: Part 1. J Bodywork 
Movement Ther. 2003;7(1):11-19. 
31. Guyton AC. Basic human neurophysiology. WB Saunders Philadelphia; 1981. 
32. Johnson KO. The roles and functions of cutaneous mechanoreceptors. Curr Opin Neurobiol. 
2001;11(4):455-461. 
33. Mitchell JH, Schmidt RF. Cardiovascular reflex control by afferent fibers from skeletal 
muscle receptors. Handbook of Physiology.The Cardiovascular System.Peripheral Circulation 
and Organ Blood Flow. 1983;3:623. 
34. Sakada S. Mechanoreceptors in fascia, periosteum and periodontal ligament. Bull Tokyo Med 
Dent Univ. 1974;21 Suppl(0):11-13. 
35. Johansson H, Sjölander P, Sojka P. A sensory role for the cruciate ligaments. Clin Orthop. 
1991;268:161-178. 
36. Noback CR, Demarest RJ. The human nervous system: Basic principles of neurobiology. 
McGraw-Hill New York; 1981. 
37. Coote JH, Perez-Gonzalez JF. The response of some sympathetic neurones to volleys in 
various afferent nerves. J Physiol. 1970;208(2):261-278. 
 102 
38. Johansson B. Circulatory responses to stimulation of somatic afferents with special reference 
to depressor effects from muscle nerves. Acta Physiol Scand Suppl. 1962;198:1-91. 
39. Eble JN. Patterns of response of the paravertebral musculature to visceral stimuli. Am J 
Physiol. 1960;198:429-433. 
40. Rood MS. Neurophysiological reactions as a basis for physical therapy. Phys Ther Rev. 
1954;34(9):444-449. 
41. Rood M. The use of sensory receptors to activate, facilitate, and inhibit motor response, 
autonomic and somatic in developmental sequence. 1962:26-37. 
42. Mason C,R. One method for assessing the effectiveness of fast brushing. Phys Ther. 
1985;65:1197-1202. 
43. Wood L, Nicol DJ, Thulin CE. The effects of skin brushing on H reflex amplitude in normal 
human subjects. Exp Physiol. 1998;83(2):175-183. 
44. Matyas TA, Galea MP, Spicer SD. Facilitation of the maximum voluntary contraction in 
hemiplegia by concomitant cutaneous stimulation. Am J Phys Med. 1986;65(3):125-134. 
45. Garland S, Hayes K. Effects of brushing on electromyographic activity and ankle dorsiflexion 
in hemiplegic subjects with foot drop. Physiother Can. 1987;39:239-247. 
46. Rittweger J. Vibration as an exercise modality: How it may work, and what its potential might 
be. Eur J Appl Physiol. 2010;108(5):877-904. 
47. Abercromby AF, Amonette WE, Layne CS, McFarlin BK, Hinman MR, Paloski WH. 
Variation in neuromuscular responses during acute whole-body vibration exercise. Med Sci 
Sports Exerc. 2007;39(9):1642. 
  103 
48. Cardinale M, Bosco C. The use of vibration as an exercise intervention. Exerc Sport Sci Rev. 
2003;31(1):3-7. 
49. Hazell TJ, Jakobi JM, Kenno KA. The effects of whole-body vibration on upper-and lower-
body EMG during static and dynamic contractions. Applied physiology, nutrition, and 
metabolism. 2007;32(6):1156-1163. 
50. Marin PJ, Bunker D, Rhea MR, Ayllon FN. Neuromuscular activity during whole-body 
vibration of different amplitudes and footwear conditions: Implications for prescription of 
vibratory stimulation. J Strength Cond Res. 2009;23(8):2311-2316.  
51. Rittweger J, Mutschelknauss M, Felsenberg D. Acute changes in neuromuscular excitability 
after exhaustive whole body vibration exercise as compared to exhaustion by squatting exercise. 
Clinical physiology and functional imaging. 2003;23(2):81-86. 
52. Roelants M, Verschueren SM, Delecluse C, Levin O, Stijnen V. Whole-body-vibration-
induced increase in leg muscle activity during different squat exercises. J Strength Cond Res. 
2006;20(1):124-129. doi: 10.1519/R-16674.1. 
53. Ronnestad BR, Holden G, Samnoy LE, Paulsen G. Acute effect of whole-body vibration on 
power, one-repetition maximum, and muscle activation in power lifters. J Strength Cond Res. 
2012;26(2):531-539.  
54. Ribot-Ciscar E, Vedel J, Roll J. Vibration sensitivity of slowly and rapidly adapting cutaneous 
mechanoreceptors in the human foot and leg. Neurosci Lett. 1989;104(1):130-135. 
55. Melnyk M, Kofler B, Faist M, Hodapp M, Gollhofer A. Effect of a whole-body vibration 
session on knee stability. Int J Sports Med. 2008;29(10):839. 
 104 
56. Nishihira Y, Iwasaki T, Hatta A, et al. Effect of whole body vibration stimulus and voluntary 
contraction on motoneuron pool. Advances in exercise and sports physiology. 2002;8(4):83-86. 
57. Bosco C, Colli R, Introini E, et al. Adaptive respsonses of human skeletal muscle to vibration 
exposure. CLINICAL PHYSIOLOGY-OXFORD-. 1999;19:183-187. 
58. Bosco C, Cardinale M, Tsarpela O. Influence of vibration on mechanical power and 
electromyogram activity in human arm flexor muscles. Eur J Appl Physiol Occup Physiol. 
1999;79(4):306-311. 
59. Issurin V, Tenenbaum G. Acute and residual effects of vibratory stimulation on explosive 
strength in elite and amateur athletes. J Sports Sci. 1999;17(3):177-182. 
60. Mileva K, Naleem AA, Biswas SK, Marwood S, Bowtell JL. Acute effects of a vibration-like 
stimulus during knee extension exercise. Med Sci Sports Exerc. 2006;38(7):1317. 
61. De Ruiter C, Van Der Linden R, Van der Zijden M, Hollander A, De Haan A. Short-term 
effects of whole-body vibration on maximal voluntary isometric knee extensor force and rate of 
force rise. Eur J Appl Physiol. 2003;88(4-5):472-475. 
62. Cormie P, Deane RS, Triplett NT, McBride JM. Acute effects of whole-body vibration on 
muscle activity, strength, and power. J Strength Cond Res. 2006;20(2):257-261. doi: 10.1519/R-
17835.1. 
63. Osawa Y, Oguma Y. Effects of resistance training with whole‐ body vibration on muscle 
fitness in untrained adults. Scand J Med Sci Sports. 2013;23(1):84-95. 
64. Merskey H, Bogduk N. Classification of chronic pain 2nd edition. Seattle: IASP Press. 
1994;1:994. 
  105 
65. Marchand S. The physiology of pain mechanisms: From the periphery to the brain. Rheumatic 
Disease Clinics of North America. 2008;34(2):285-309. 
66. Palmieri-Smith RM, Villwock M, Downie B, Hecht G, Zernicke R. Pain and effusion and 
quadriceps activation and strength. Journal of athletic training. 2013;48(2):186-191. 
67. Park J, Hopkins JT. Induced anterior knee pain immediately reduces involuntary and 
voluntary quadriceps activation. Clinical Journal of Sport Medicine. 2013;23(1):19-24. 
68. Graven-Nielsen T, Svensson P, Arendt-Nielsen L. Effects of experimental muscle pain on 
muscle activity and co-ordination during static and dynamic motor function. 
Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control. 
1997;105(2):156-164. 
69. Hassan B, Doherty S, Mockett S, Doherty M. Effect of pain reduction on postural sway, 
proprioception, and quadriceps strength in subjects with knee osteoarthritis. Ann Rheum Dis. 
2002;61(5):422-428. 
70. Goats GC. Massage--the scientific basis of an ancient art: Part 2. physiological and 
therapeutic effects. Br J Sports Med. 1994;28(3):153-156.  
71. Melzack R. Gate control theory: On the evolution of pain concepts. . 1996;5(2):128-138. 
72. Walsh DM, Lowe AS, McCormack K, Willer J, Baxter GD, Allen JM. Transcutaneous 
electrical nerve stimulation: Effect on peripheral nerve conduction, mechanical pain threshold, 
and tactile threshold in humans. Arch Phys Med Rehabil. 1998;79(9):1051-1058. 
 106 
73. Hopkins JT, Ingersoll CD, Edwards J, Klootwyk TE. Cryotherapy and transcutaneous electric 
neuromuscular stimulation decrease arthrogenic muscle inhibition of the vastus medialis after 
knee joint effusion. Journal of athletic training. 2002;37(1):25. 
74. Pietrosimone B, Hart J, Saliba S, Hertel J, Ingersoll C. Immediate effects of transcutaneous 
electrical nerve stimulation and focal knee joint cooling on quadriceps activation. Medicine 
Science in Sports Exercise. 2009;41(6):1175. 
75. Cetin N, Aytar A, Atalay A, Akman MN. Comparing hot pack, short-wave diathermy, 
ultrasound, and TENS on isokinetic strength, pain, and functional status of women with 
osteoarthritic knees: A single-blind, randomized, controlled trial. American Journal of Physical 
Medicine & Rehabilitation. 2008;87(6):443-451. 
76. Kaada B. Increase of plasma β-endorphins in connective tissue massage. General 
Pharmacology: The Vascular System. 1989;20(4):487-489. 
77. Arroyo-Morales M, Fernandez-Lao C, Ariza-Garcia A, et al. Psychophysiological effects of 
preperformance massage before isokinetic exercise. J Strength Cond Res. 2011;25(2):481-488.  
78. Hemmings B, Smith M, Graydon J, Dyson R. Effects of massage on physiological restoration, 
perceived recovery, and repeated sports performance. Br J Sports Med. 2000;34(2):109-114. 
79. Hilbert JE, Sforzo G, Swensen T. The effects of massage on delayed onset muscle soreness. 
Br J Sports Med. 2003;37(1):72-75. 
80. McKechnie GJ, Young WB, Behm DG. Acute effects of two massage techniques on ankle 
joint flexibility and power of the plantar flexors. J Sports Sci Med. 2007;6(4):498-504. 
  107 
81. Robertson A, Watt J, Galloway S. Effects of leg massage on recovery from high intensity 
cycling exercise. Br J Sports Med. 2004;38(2):173-176. 
82. Wiktorsson-Moller M, Öberg B, Ekstrand J, Gillquist J. Effects of warming up, massage, and 
stretching on range of motion and muscle strength in the lower extremity. Am J Sports Med. 
1983;11(4):249-252. 
83. Drover JM, Forand DR, Herzog W. Influence of active release technique on quadriceps 
inhibition and strength: A pilot study. J Manipulative Physiol Ther. 2004;27(6):408-413.  
84. Jain MK, Berg RA, Tandon GP. Mechanical stress and cellular metabolism in living soft 
tissue composites. Biomaterials. 1990;11(7):465-472. 
85. Steward RL,Jr, Cheng CM, Ye JD, Bellin RM, LeDuc PR. Mechanical stretch and shear flow 
induced reorganization and recruitment of fibronectin in fibroblasts. Sci Rep. 2011;1:147.  
86. Lee E, Kim DY, Chung E, Lee EA, Park KS, Son Y. Transplantation of cyclic stretched 
fibroblasts accelerates the wound-healing process in streptozotocin-induced diabetic mice. Cell 
Transplant. 2013. 
87. Mallouk N, Allard B. Stretch-induced activation of ca(2+)-activated K(+) channels in mouse 
skeletal muscle fibers. Am J Physiol Cell Physiol. 2000;278(3):C473-9. 
88. Hibberd MG, Trentham DR. Relationships between chemical and mechanical events during 
muscular contraction. Annu Rev Biophys Biophys Chem. 1986;15(1):119-161. 
89. Stein R, Bobet J, Oğuztöreli M, Fryer M. The kinetics relating calcium and force in skeletal 
muscle. Biophys J. 1988;54(4):705-717. 
 108 
90. Zot AS, Potter JD. Structural aspects of troponin-tropomyosin regulation of skeletal muscle 
contraction. Annu Rev Biophys Biophys Chem. 1987;16(1):535-559. 
91. Loy RE, Orynbayev M, Xu L, et al. Muscle weakness in Ryr1I4895T/WT knock-in mice as a 
result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic 
reticulum. J Gen Physiol. 2011;137(1):43-57.  
92. Boitano S, Sanderson MJ, Dirksen ER. A role for ca(2+)-conducting ion channels in 
mechanically-induced signal transduction of airway epithelial cells. J Cell Sci. 1994;107 ( Pt 
11)(Pt 11):3037-3044. 
93. Dubrovsky V. Changes in muscle and venous blood flow after massage. Soviet Sports Review. 
1983;18(3):134-135. 
94. Hansen TI, Kristensen JH. Effect of massage, shortwave diathermy and ultrasound upon 
133Xe disappearance rate from muscle and subcutaneous tissue in the human calf. Scand J 
Rehabil Med. 1973;5(4):179-182. 
95. Hovind H, Nielsen SL. Effect of massage on blood flow in skeletal muscle. Scand J Rehabil 
Med. 1974;6(2):74-77. 
96. Sargeant AJ. Effect of muscle temperature on leg extension force and short-term power output 
in humans. Eur J Appl Physiol Occup Physiol. 1987;56(6):693-698. 
97. Bergh U, Ekblom B. Influence of muscle temperature on maximal muscle strength and power 
output in human skeletal muscles. Acta Physiol Scand. 1979;107(1):33-37. 
98. Longworth JC. Psychophysiological effects of slow stroke back massage in normotensive 
females. Advances in Nursing Science. 1982;4(4):44-61. 
  109 
99. Drust B, Atkinson G, Gregson W, French D, Binningsley D. The effects of massage on intra 
muscular temperature in the vastus lateralis in humans. Int J Sports Med. 2003;24(06):395-399. 
100. Gray SR, De Vito G, Nimmo MA, Farina D, Ferguson RA. Skeletal muscle ATP turnover 
and muscle fiber conduction velocity are elevated at higher muscle temperatures during maximal 
power output development in humans. Am J Physiol Regul Integr Comp Physiol. 
2006;290(2):R376-82.  
101. Farina D, Arendt-Nielsen L, Graven-Nielsen T. Effect of temperature on spike-triggered 
average torque and electrophysiological properties of low-threshold motor units. J Appl Physiol 
(1985). 2005;99(1):197-203.  
102. Black DW. Treatment of knee arthrofibrosis and quadriceps insufficiency after patellar 
tendon repair: A case report including use of the graston technique. Int J Ther Massage 
Bodywork. 2010;3(2):14-21. 
103. Mikesky AE, Bahamonde RE, Stanton K, Alvey T, Fitton T. Acute effects of the stick on 
strength, power, and flexibility. J Strength Cond Res. 2002;16(3):446-450. 
104. Arazi H, Asadi A, Hoseini K. Comparison of two different warm-ups (static-stretching and 
massage): Effects on flexibility and explosive power. Acta Kinesiologica. 2012;6(1):55-59. 
105. Weerapong P, Hume PA, Kolt GS. The mechanisms of massage and effects on performance, 
muscle recovery and injury prevention. Sports Med. 2005;35(3):235-256. 
106. Grimes DA, Schulz KF. An overview of clinical research: The lay of the land. The Lancet. 
2002;359(9300):57-61. 
 110 
107. Hammer WI. The effect of mechanical load on degenerated soft tissue. J Bodyw Mov Ther. 
2008;12(3):246-256.  
108. Papa JA. Conservative management of de quervain's stenosing tenosynovitis: A case report. 
J Can Chiropr Assoc. 2012;56(2):112-120. 
109. Papa JA. Conservative management of a lumbar compression fracture in an osteoporotic 
patient: A case report. J Can Chiropr Assoc. 2012;56(1):29-39. 
110. Looney B, Srokose T, Fernandez-de-las-Penas C, Cleland JA. Graston instrument soft tissue 
mobilization and home stretching for the management of plantar heel pain: A case series. J 
Manipulative Physiol Ther. 2011;34(2):138-142.  
111. Daniels CJ, Morrell AP. Chiropractic management of pediatric plantar fasciitis: A case 
report. J Chiropr Med. 2012;11(1):58-63.  
112. Papa JA. Two cases of work-related lateral epicondylopathy treated with graston 
technique(R) and conservative rehabilitation. J Can Chiropr Assoc. 2012;56(3):192-200. 
113. Papa JA. Conservative management of achilles tendinopathy: A case report. J Can Chiropr 
Assoc. 2012;56(3):216-224. 
114. Miners AL, Bougie TL. Chronic achilles tendinopathy: A case study of treatment 
incorporating active and passive tissue warm-up, graston technique, ART, eccentric exercise, and 
cryotherapy. J Can Chiropr Assoc. 2011;55(4):269-279. 
115. Bayliss AJ, Klene FJ, Gundeck EL, Loghmani MT. Treatment of a patient with post-natal 
chronic calf pain utilizing instrument-assisted soft tissue mobilization: A case study. The Journal 
of manual & manipulative therapy. 2011;19(3):127. 
  111 
116. Abels KM. The impact of foam rolling on explosive strength and excitability of the motor 
neuron pool. 2013. 
117. Sullivan K, Silvey D, Button D, Behm D. Roller-massager application to the hamstrings 
increases sit-and-reach range of motion within five to ten seconds without performance 
impairments. International journal of sports physical therapy. 2013;8(3):228-236. 
118. Healey KC, Hatfield DL, Blanpied P, Dorfman LR, Riebe D, Hatfield DL. The effects of 
myofascial release with foam rolling on performance. Journal of strength and conditioning 
research/National Strength & Conditioning Association. 2013. 
119. Brummitt J. The role of massage in sports performance and rehabilitation: Current evidence 
and future direction. N Am J Sports Phys Ther. 2008;3(1):7-21. 
120. Callaghan MJ. The role of massage in the management of the athlete: A review. Br J Sports 
Med. 1993;27(1):28-33. 
121. Goats GC. Massage--the scientific basis of an ancient art: Part 1. the techniques. Br J Sports 
Med. 1994;28(3):149-152. 
122. Cyriax JH. Clinical applications of massage. Manipulation, traction, and massage. 
1980:152-169. 
123. Jönhagen S, Ackermann P, Eriksson T, Saartok T, Renström PA. Sports massage after 
eccentric exercise. Am J Sports Med. 2004;32(6):1499-1503. 
124. Tiidus PM. Manual massage and recovery of muscle function following exercise: A 
literature review. J Orthop Sports Phys Ther. 1997;25(2):107-112. 
 112 
125. Mancinelli CA, Davis DS, Aboulhosn L, Brady M, Eisenhofer J, Foutty S. The effects of 
massage on delayed onset muscle soreness and physical performance in female collegiate 
athletes. Physical Therapy in Sport. 2006;7(1):5-13. 
126. Micklewright D, Griffin M, Gladwell V, Beneke R. Mood state response to massage and 
subsequent exercise performance. The Sport Psychologist. 2005;19:234-250. 
127. Ogai R, Yamane M, Matsumoto T, Kosaka M. Effects of petrissage massage on fatigue and 
exercise performance following intensive cycle pedalling. Br J Sports Med. 2008;42(10):834-838.  
128. Brooks CP, Woodruff LD, Wright LL, Donatelli R. The immediate effects of manual 
massage on power-grip performance after maximal exercise in healthy adults. J Altern 
Complement Med. 2005;11(6):1093-1101. 
129. Dawson B, Gow S, Modra S, Bishop D, Stewart G. Effects of immediate post-game 
recovery procedures on muscle soreness, power and flexiblity levels over the next 48 hours. 
Journal of Science and Medicine in Sport. 2005;8(2):210-221. 
130. Weber MD, Servedio FJ, Woodall WR. The effects of three modalities on delayed onset 
muscle soreness. J Orthop Sports Phys Ther. 1994;20(5):236-242.  
131. Leahy PM, Patterson T, inventorspatent Patent No. 6,283,916. September 4, 2001, 2001. 
132. Evetovich TK, Nauman NJ, Conley DS, Todd JB. Effect of static stretching of the biceps 
brachii on torque, electromyography, and mechanomyography during concentric isokinetic 
muscle actions. J Strength Cond Res. 2003;17(3):484-488. 
133. Fowles JR, Sale DG, MacDougall JD. Reduced strength after passive stretch of the human 
plantarflexors. J Appl Physiol (1985). 2000;89(3):1179-1188. 
  113 
134. Kokkonen J, Nelson AG, Cornwell A. Acute muscle stretching inhibits maximal strength 
performance. Res Q Exerc Sport. 1998;69(4):411-415. 
135. Marek SM, Cramer JT, Fincher AL, et al. Acute effects of static and proprioceptive 
neuromuscular facilitation stretching on muscle strength and power output. J Athl Train. 
2005;40(2):94-103. 
136. Nelson AG, Kokkonen J, Arnall DA. Acute muscle stretching inhibits muscle strength 
endurance performance. J Strength Cond Res. 2005;19(2):338-343.  
137. Kukulka CG, Haberichter PA, Mueksch AE, Rohrberg MG. Muscle pressure effects on 
motoneuron excitability A special communication. Phys Ther. 1987;67(11):1720-1722. 
138. Carcia CR, Kivlan BR, Scibek JS. Time to peak force is related to frontal plane landing 
kinematics in female athletes. Physical Therapy in Sport. 2012;13(2):73-79. 
139. Blazevich AJ, Gill N, Newton RU. Reliability and validity of two isometric squat tests. J 
Strength Cond Res. 2002;16(2):298-304. 
140. Binkley JM, Stratford PW, Lott SA, Riddle DL. The lower extremity functional scale 
(LEFS): Scale development, measurement properties, and clinical application. north american 
orthopaedic rehabilitation research network. Phys Ther. 1999;79(4):371-83. 
141. Williamson A, Hoggart B. Pain: A review of three commonly used pain rating scales. J Clin 
Nurs. 2005;14(7):798-804.  
142. Jensen MP, McFarland CA. Increasing the reliability and validity of pain intensity 
measurement in chronic pain patients. Pain. 1993;55(2):195-203. 
 114 
143. Stratford PW, Spadoni G. The reliability, consistency, and clinical application of a numeric 
pain rating scale. PhysioTherapy Canada. 2001;53(2):88-91. 
144. Jakobsen TL, Christensen M, Christensen SS, Olsen M, Bandholm T. Reliability of knee 
joint range of motion and circumference measurements after total knee arthroplasty: Does tester 
experience matter? Physiother Res Int. 2010;15(3):126-134.  
145. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J.: L. 
Erlbaum Associates; 1988:567. http://www.loc.gov/catdir/enhancements/fy0731/88012110-
d.html. 
146. de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM. Minimal changes 
in health status questionnaires: Distinction between minimally detectable change and minimally 
important change. Health Qual Life Outcomes. 2006;4:54. 
147. Schaub PA, Worrell TW. EMG activity of six muscles and VMO: VL ratio determination 
during a maximal squat exercise. J Sport Rehabil. 1995;4:195-202. 
148. Ek AC, Gustavsson G, Lewis DH. The local skin blood flow in areas at risk for pressure 
sores treated with massage. Scand J Rehabil Med. 1985;17(2):81-86. 
149. Bell AJ. Massage and the physiotherapist. Physiotherapy. 1964;50:406-408. 
150. Franklin NC, Ali MM, Robinson AT, Norkeviciute E, Phillips SA. Massage therapy restores 
peripheral vascular function after exertion. Arch Phys Med Rehabil. 2014;95(6):1127-1134. 
151. Yerys S, Makofsky H, Byrd C, Pennachio J, Cinkay J. Effect of mobilization of the anterior 
hip capsule on gluteus maximus strength. Journal of Manual & Manipulative Therapy. 
2002;10(4):218-224. 
  115 
152. Makofsky H, Panicker S, Abbruzzese J, et al. Immediate effect of grade IV inferior hip joint 
mobilization on hip abductor torque: A pilot study. The Journal of manual & manipulative 
therapy. 2007;15(2):103. 
153. Ghanbari A, Kamalgharibi S. Effect of knee joint mobilization on quadriceps muscle 
strength. International Journal of Health and Rehabilitation Sciences (IJHRS). 2013;2(4):186-
191. 
154. Rhea MR, Kenn JG. The effect of acute applications of whole-body vibration on the iTonic 
platform on subsequent lower-body power output during the back squat. J Strength Cond Res. 
2009;23(1):58-61. 
155. Jacobs PL, Burns P. Acute enhancement of lower-extremity dynamic strength and flexibility 
with whole-body vibration. J Strength Cond Res. 2009;23(1):51-57. 
156. McBride JM, Nuzzo JL, Dayne AM, Israetel MA, Nieman DC, Triplett NT. Effect of an 
acute bout of whole body vibration exercise on muscle force output and motor neuron 
excitability. J Strength Cond Res. 2010;24(1):184-189. 
157. Cochrane D. Vibration exercise: The potential benefits. Int J Sports Med. 2011;32(2):75. 
158. Hopkins T, Pak J, Robertshaw A, Feland J, Hunter I, Gage M. Whole body vibration and 
dynamic restraint. Int J Sports Med. 2008;29(05):424-428. 
159. Cochrane DJ, Sartor F, Winwood K, Stannard SR, Narici MV, Rittweger J. A comparison of 
the physiologic effects of acute whole-body vibration exercise in young and older people. Arch 
Phys Med Rehabil. 2008;89(5):815-821. 
 116 
160. Cochrane DJ, Stannard SR, Firth EC, Rittweger J. Acute whole-body vibration elicits post-
activation potentiation. Eur J Appl Physiol. 2010;108(2):311-319. 
161. Comfort P, Stewart A, Bloom L, Clarkson B. Relationships between strength, sprint and 
jump performance in well trained youth soccer players. J Strength Cond Res. 2013.  
162. Trochim WMK. Mutliple group effects. 
(http://www.socialresearchmethods.net/kb/intmult.php.) Updated 2006. Accessed October, 12, 
2014. 
163. Grindstaff TL, Hertel J, Beazell JR, Magrum EM, Ingersoll CD. Effects of lumbopelvic joint 
manipulation on quadriceps activation and strength in healthy individuals. Man Ther. 
2009;14(4):415-420. 
164. Sapega AA, Drillings G. The definition and assessment of muscular power. Journal of 
Orthopaedic & Sports Physical Therapy. 1983;5(1):7-9. 
165. Foldvari M, Clark M, Laviolette LC, et al. Association of muscle power with functional 
status in community-dwelling elderly women. J Gerontol A Biol Sci Med Sci. 2000;55(4):M192-
9. 
166. Skelton DA, Kennedy J, Rutherford OM. Explosive power and asymmetry in leg muscle 
function in frequent fallers and non-fallers aged over 65. Age Ageing. 2002;31(2):119-125. 
167. Hawley JA, Noakes TD. Peak power output predicts maximal oxygen uptake and 
performance time in trained cyclists. Eur J Appl Physiol Occup Physiol. 1992;65(1):79-83. 
  117 
168. Paavolainen L, Hakkinen K, Hamalainen I, Nummela A, Rusko H. Explosive-strength 
training improves 5-km running time by improving running economy and muscle power. J Appl 
Physiol (1985). 1999;86(5):1527-1533. 
169. Dowling JJ, Vamos L. Identification of kinetic and temporal factors related to vertical jump 
performance. Journal of Applied Biomechanics. 1993;9:95-95. 
170. Cronin JB, Hansen KT. Strength and power predictors of sports speed. J Strength Cond Res. 
2005;19(2):349-357. 
171. Bennell K, Dobson F, Hinman R. Measures of physical performance assessments: Self‐
Paced walk test (SPWT), stair climb test (SCT), Six‐ Minute walk test (6MWT), chair stand test 
(CST), timed up & go (TUG), sock test, lift and carry test (LCT), and car task. Arthritis care & 
research. 2011;63(S11):S350-S370. 
172. Kivlan BR, Martin RL. Functional performance testing of the hip in athletes: A systematic 
review for reliability and validity. Int J Sports Phys Ther. 2012;7(4):402-412. 
173. Byrne C, Twist C, Eston R. Neuromuscular function after exercise-induced muscle damage. 
Sports medicine. 2004;34(1):49-69. 
174. Graven‐ Nielsen T, Lund H, Arendt‐ Nielsen L, Danneskiold‐ Samsøe B, Bliddal H. 
Inhibition of maximal voluntary contraction force by experimental muscle pain: A centrally 
mediated mechanism. Muscle Nerve. 2002;26(5):708-712. 
175. Howell JN, Chleboun G, Conatser R. Muscle stiffness, strength loss, swelling and soreness 
following exercise-induced injury in humans. J Physiol. 1993;464:183-196. 
 118 
176. McNair PJ, Marshall RN, Maguire K. Swelling of the knee joint: Effects of exercise on 
quadriceps muscle strength. Arch Phys Med Rehabil. 1996;77(9):896-899. 
177. Jensen K, Graf BK. The effects of knee effusion on quadriceps strength and knee 
intraarticular pressure. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 
1993;9(1):52-56. 
178. Call MH. The Effects of Wearing Prophylatic Knee Sleeves/Braces on Selected Isokinetic 
Measures During a Velocity Spectrum Knee Extension Test. 1998. 
179. Kim H, Lee B. The effects of kinesio tape on isokinetic muscular function of horse racing 
jockeys. Journal of Physical Therapy Science. 2013;25(10):1273. 
180. Slupik A, Dwornik M, Bialoszewski D, Zych E. Effect of kinesio taping on bioelectrical 
activity of vastus medialis muscle. preliminary report. Ortop Traumatol Rehabil. 2007;9(6):644-
651. 
181. MacGregor K, Gerlach S, Mellor R, Hodges PW. Cutaneous stimulation from patella tape 
causes a differential increase in vasti muscle activity in people with patellofemoral pain. Journal 
of Orthopaedic Research. 2005;23(2):351-358. 
182. Osorio JA, Vairo GL, Rozea GD, et al. The effects of two therapeutic patellofemoral taping 
techniques on strength, endurance, and pain responses. Physical Therapy in Sport. 
2013;14(4):199-206. 
183. Christou EA. Patellar taping increases vastus medialis oblique activity in the presence of 
patellofemoral pain. Journal of Electromyography and Kinesiology. 2004;14(4):495-504. 
  119 
184. Wong OM, Cheung RT, Li RC. Isokinetic knee function in healthy subjects with and 
without kinesio taping. Physical Therapy in Sport. 2012;13(4):255-258. 
185. Fu T, Wong AM, Pei Y, Wu KP, Chou S, Lin Y. Effect of kinesio taping on muscle strength 
in athletes—a pilot study. Journal of Science and Medicine in Sport. 2008;11(2):198-201. 
186. Csapo R, Herceg M, Alegre LM, Crevenna R, Pieber K. Do kinaesthetic tapes affect 
plantarflexor muscle performance? J Sports Sci. 2012;30(14):1513-1519. 
187. Chang H, Chou K, Lin J, Lin C, Wang C. Immediate effect of forearm kinesio taping on 
maximal grip strength and force sense in healthy collegiate athletes. Physical Therapy in Sport. 
2010;11(4):122-127. 
188. Briem K, Eythörsdöttir H, Magnúsdóttir RG, Pálmarsson R, Rúnarsdöttir T, Sveinsson T. 
Effects of kinesio tape compared with nonelastic sports tape and the untaped ankle during a 
sudden inversion perturbation in male athletes. journal of orthopaedic & sports physical therapy. 
2011;41(5):328-335. 
189. Vercelli S, Sartorio F, Foti C, et al. Immediate effects of kinesiotaping on quadriceps muscle 
strength: A single-blind, placebo-controlled crossover trial. Clin J Sport Med. 2012;22(4):319-
326.  
190. Williams S, Whatman C, Hume PA, Sheerin K. Kinesio taping in treatment and prevention 
of sports injuries. Sports medicine. 2012;42(2):153-164. 
191. Ziman AP, Ward CW, Rodney GG, Lederer WJ, Bloch RJ. Quantitative measurement of ca< 
sup> 2 in the sarcoplasmic reticulum lumen of mammalian skeletal muscle. Biophys J. 
2010;99(8):2705-2714. 
 120 
192. Hopkins WG. Measures of reliability in sports medicine and science. Sports Med. 
2000;30(1):1-15. 
 
  
  121 
 
APPENDIX A. VALIDITY OF COMPUTERIZED LEG PRESS MACHINE 
 
 
 
 To establish evidence of validity, a pilot study was performed to determine the 
agreement of the maximum force output recorded with a digital force dynamometer 
(criterion) versus the computerized leg press machine (practical test) during a maximal 
isometric squat test. A digital force dynamometer (Microfet 2 Manual Muscle Testing 
Handheld Dynamometer; Salt Lake City; Utah) that was calibrated to within one 
hundredth of a Newton was secured to the surface of the foot plate of the computerized 
leg press machine.  The subject then placed their foot on the center of the dynamometer 
and was asked to push through their foot as hard as possible.  The agreement of the force 
computed on the computerized leg press machine to the dynamometer was determined for 
21 consecutive trials using a Pearson correlation coefficient.  The computerized leg press 
machine demonstrated evidence of excellent criterion validity to the digital force 
dynamometer with a Pearson correlation coefficient of 0.99.  The Typical Error of the 
Estimate was also computed through linear regression.192  The Typical Error of the 
Estimate represents the typical amount by which the estimate is wrong for any given 
subject.  The analysis revealed the Typical Error of the Estimate to be 10.69 Newtons 
(95% CI: 8.13-15.62 Newtons).   
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APPENDIX B. RELIABILITY OF THE COMPUTERIZED LEG PRESS MACHINE 
 
 
 A pilot study was performed to establish test-retest reliability of the Computerized 
Leg Press Machine.  Twelve subjects healthy performed 3 repetitions of maximal 
isometric testing on the computerized leg press machine. After a 12 minute rest, maximal 
isometric testing on the computerized leg press machine was repeated with an additional 
3 repetitions. An intra-class correlation coefficient (ICC) was computed from the average 
of the first 3 repetitions and the average of the final 3 repetitions of maximal isometric 
testing. Test-retest reliability of maximal isometric testing using the computerized leg 
press machine was determined with an ICC(2,1) of 0.99.  The standard error of the 
measurement is a reliability measure that estimates the given error in a set of measures.  
The standard error of the measurement was determined to be a 2.7 %change in maximal 
force output.  The minimal detectable change represents the smallest amount of change in 
a given measure that is not attributable to measurement error.  The minimal detectable 
change is computed as a confidence interval of the standard error of the measurement.  
Using a 95% confidence interval, the minimal detectable change was determined to be 
7.5 %change in maximal force output.     
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APPENDIX C.  ANALYSIS OF LEARNING AND FATIGUE EFFECT 
 
 
 A repeated measures analysis of variance was performed to determine if trial 
number influenced the subject’s test performance on an isometric squat test.  Determining 
a learning effect or fatigue effect is important in establishing a testing protocol that best 
represents the subject’s true performance. A learning effect would be represented by an 
improvement of test performance with repeated trials.  A fatigue effect would be 
represented by a decline in test performance with repeated trials. Fourteen healthy 
subjects performed 10 repeated trials of isometric testing on a computerized leg press 
machine.  The results indicated a significant effect of trial number to isometric force 
output (F(9,5) = 5.27, p<0.05).  Analysis of a plot of the estimated marginal means 
(Figure 9) shows a learning effect that occurs between trial 1 and 2.  On average this 
accounted for approximately a 5% increase between trial 1 and 2.  After trial 2, there 
appears to be a gradual linear decline in performance indicating the possibility of fatigue 
until trial 9.  The average decline in performance between trial 2 and trial 9 is 
approximately 6%.  The pairwise comparisons between trials, however, did not 
demonstrate a significant difference between any of the 10 trials.  Although pairwise 
comparisons of trial 1 and trial 2, and trial 2 and trial 9 did not reach statistical 
significance, the testing protocol should account for the tendency of an initial learning 
effect and the possibility of a gradual fatigue effect with repeated testing.  Carcia et al. 138 
described a familiarization protocol for unilateral isometric testing on a computerized leg 
press machine. Based on data from our pilot study, the familiarization protocol described 
by Carcia et al. 138 would account for an initial learning effect and limit fatigue by 
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averaging only three trials performed at maximal effort.   For this reason, the 
familiarization protocol described by Carcia et al.138 was adopted for the proposed 
research study. 
 
 
Figure 9.  Estimated Marginal Means of the Trial Number 
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Appendix D.  The frequency of gender, lower extremity dominance, and diagnosis of the 
subjects according to treatment group. 
 
 Subject 
Number 
Gender Lower Extremity 
Dominance 
Diagnosis 
Astym     
 1 F R HAMSTRING STRAIN 
 
2 F R 
TROCHANTERIC 
BURSITIS 
 
4 F L 
ACHILLES 
TENDINOPATHY 
 
8 M R 
DISTAL ITB FRICTION 
SYNDROME 
 9 M R HAMSTRING STRAIN 
 15 F R PATELLOFEMORAL PAIN 
 
17 F R 
DISTAL ITB FRICTION 
SYNDROME 
 
21 F R 
FEMOROACETABULAR 
IMPINGEMENT 
 24 M R PLANTAR FASCIITIS 
 25 F R LABRAL TEAR 
 
27 F R 
TIBIALIS POSTERIOR 
TENDINOPATHY 
 
33 F R 
DISTAL ITB FRICTION 
SYNDROME 
 40 F R PATELLOFEMORAL PAIN 
 44 F R PLANTAR FASCIITIS 
 45 F R MENISCAL TEAR 
Control     
 
3 F R 
POSTERIOR TIBIALIS 
TENDINOPATHY 
 5 F R MCL SPRAIN 
 7 M R ADDUCTOR STRAIN 
 13 F L ANKLE SPRAIN 
 14 F R PATELLOFEMORAL PAIN 
 20 M R PATELLOFEMORAL PAIN 
 22 M R PLANTAR FASCIITIS 
 26 M R PATELLOFEMORAL PAIN 
 29 F R ANKLE SPRAIN 
 30 F R KNEE OSTEOARTHRITIS 
 34 M R PLICA 
 38 F R HAMSTRING 
 41 F R PATELLOFEMORAL 
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PAIN/QUAD STRAIN 
 
42 F R 
FEMOROACETABULAR 
IMPINGEMENT 
 
43 F R 
POSTERIOR TIBIALIS 
TENDINOPATHY 
Placebo      
 6 F R MCL SPRAIN 
 
10 M R 
PATELLAR 
DISLOCATION 
 11 F  R PATELLOFEMORAL PAIN 
 12 F R SHIN SPLINTS 
 16 M R PLANTAR FASCIITIS 
 18 F R PES ANSERINE BURSITIS 
 19 F R PATELLOFEMORAL PAIN 
 23 F R QUAD STRAIN 
 28 M R HAMSTRING 
 31 M L HAMSTRING 
 32 F R QUAD STRAIN 
 35 M L HAMSTRING 
 36 F R PATELLOFEMORAL PAIN 
 37 F R MENISCAL TEAR 
 39 M R PLANTAR FASCIITIS 
 6 F R MCL SPRAIN 
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Appendix E.  Raw Data 
Sub# Group Age Ht Wt  LEFS % 
Deficit 
Pre-
Pain 
Post-
Pain 
Pre-
test 
(N) 
Post-
Test 
(N) 
%Diff 
1 A 53 165 60 50 23 5 1 1082 1308 21 
2 A 45 172 68 68 19 3 0 658 864 31 
3 C 49 155 51 65 30 2 2 607 753 29 
4 A 28 170 70 70 11 0 0 1191 1543 29 
5 C 58 165 73 66 11 2 2 1165 1185 2 
6 B 62 162 73 52 30 2 0 595 431 -38 
7 C 24 175 68 46 26 0 0 1794 1341 -25 
8 A 21 175 79 69 11 0 1 2465 2909 18 
9 A 33 185 86 69 29 5 3 1068 1442 35 
10 B 39 183 84 62 12 2 6 1732 1681 -3 
11 B 32 152 41 67 19 2 2 950 937 -4 
12 B 26 165 64 57 10 6 8 1391 1338 -4 
13 C 41 163 55 70 23 2 2 659 686 4 
14 C 20 160 52 69 13 2 6 1732 1681 -3 
15 A 47 165 52 70 12 0 0 832 1045 26 
16 B 41 183 75 70 33 0 0 538 503 -7 
17 A 54 165 67 70 32 5 5 653 733 13 
18 B 56 152 72 65 14 5 5 371 350 -6 
19 B 35 160 51 70 23 2 2 737 778 6 
20 C 24 170 79 70 13 0 5 2672 2128 -20 
21 A 48 157 64 40 19 5 3 731 957 31 
22 C 28 173 107 62 33 2 2 1333 1261 -5 
23 B 62 163 70 60 26 3 3 868 845 -3 
24 A 40 165 70 67 20 3 3 1670 1805 8 
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25 A 43 167 57 57 18 1 2 726 719 -1 
26 C 36 191 102 63 11 0 4 1111 1022 -8 
27 A  32 168 88 46 20 0 0 836 764 -9 
28 B 36 180 75 60 19 3 5 809 660 -18 
29 C 54 175 97 50 50 3 3 461 581 26 
30 C 28 170 67 54 25 7 5 212 234 10 
31 B 49 167 64 42 10 1 1 659 625 -5 
32 B 42 160 54 43 26 1 1 491 491 0 
33 A 53 125 55 51 46 0 0 354 475 34 
34 C 38 180 100 63 20 6 7 1122 855 -31 
35 B 27 193 95 69 10 2 2 1936 1736 -10 
36 B 28 163 68 65 10 0 4 1923 1861 -3 
37 B 65 165 79 55 17 3 5 447 408 -9 
38 C 32 157 63 59 10 5 5 564 546 -3 
39 B 46 170 78 60 12 0 0 1024 1127 10 
40 A 20 178 77 56 17 0 4 1364 1445 6 
41 C 23 170 60 63 10 0 0 676 715 6 
42 C 24 178 93 45 21 4 5 1053 1172 11 
43 C 47 170 54 59 13 3 3 487 420 -14 
44 A 49 168 75 62 28 2 2 660 506 -30 
45 A 61 162 59 59 21 4 1 619 742 20 
A= Astym treatment group; B= Placebo treatment group; C= Control group:  
LEFS= Lower Extremity Functional Score. 
